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Intrinsically disordered (ID) regions of proteins, lacking stable tertiary structure, are 
malleable and sensitive regulators of cell functions. Allostery is transmittance of a perturbation at 
one region to distant sites of the same molecule, allowing for precise control of macromolecular 
function. Nature preferentially uses both ID regions and allostery to regulate protein function, as 
observed in transcription factors. This motivated us to investigate whether and how ID regions can 
facilitate allostery.  
The classic allosteric models all feature a static structural and single molecule view of 
allostery and are not applicable to study allostery mediated by ID regions. To address this 
limitation, our group has developed the Ensemble Allosteric Model (EAM), which views allostery 
as an effector binding driven shift in ensemble probabilities. It is a thermodynamic and 
quantitative model that can be applied to structured proteins, ID proteins and mixed proteins. 
In this thesis project, I investigated the intra- and inter- domain allostery mediated by the 
ID regions in human glucocorticoid receptor (GR). Through thermodynamic and functional 
studies on eight GR translational isoforms, I found that the ID GR N terminal domain (NTD) is 
composed of two functionally distinct regions, unfavorably coupled with each other, and both of 
them are favorably coupled to the DNA binding domain (DBD).  
Based on these experimental constraints, an EAM was built for GR and reasonable 
thermodynamic parameter combinations were found to describe both the transcriptional activity 
and binding affinity of different translational isoforms. We found that GR uses these competing 
energetic couplings, which are modulated in different translational isoforms, to provide tunable 
responses to environmental cues.  
 iii 
In the context of the EAM predictions, mutagenesis was carried out in different regions of 
GR and the influence on transcriptional activity and binding affinity was assayed to pinpoint the 
molecular basis of allostery, which paves a way for allosteric drug design. This study suggests a 
unifying strategy to investigate thermodynamics and the molecular basis of allostery in any 
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Chapter 1- Introduction 
1.1 Allostery, classic allosteric models and the Ensemble Allosteric Model (EAM) 
Allostery is the process by which remote sites of a system are energetically coupled to elicit 
a functional response, which manifests itself as “action at a distance”. It plays important roles in 
signal transduction, gene transcription and metabolic homeostasis by endowing the cells with a 
sensitive responsiveness to environmental cues [1]. Due to its functional importance, 
understanding the structural, molecular and energetic basis of allostery in individual systems is 
crucial to dissecting the mechanism. Historically, the structural view of allostery has guided the 
field, represented by two classic models, the concerted MWC (Monod-Wyman-Changeux) 
model[2] and the sequential KNF (Koshland-Nemethy-Filmer) model [3]. The characteristic 
feature of the MWC model is that the conformational change between the two domains is coupled. 
In contrast, the classic feature of the KNF model is that conformational change and ligand binding 
are coupled [4]. Both of these two models assume a static structural view of allostery. However, 
accumulating evidence has called into question these classic views of allostery, especially the 
hyper-abundance of intrinsic disorder in allosteric regulatory proteins, such as transcription factors 
[5]. Recently, the Ensemble Allosteric Model (EAM) [6-8], which is pioneered by our lab, may 
provide insights into these systems. In this model, the molecule without effectors is considered as 
an ensemble of pre-existing conformations, and effector binding is treated as an energetic 
perturbation of the ensemble to redistribute the microstates that are favorable or unfavorable to the 
second binding partner. It only considers the intrinsic energetics of the system, does not depend on 
a crystallographic structure, and is more general than the classic models. All the allosteric 
coupling discussed in this dissertation is based on the ensemble allosteric concept. 
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1.2 The importance of intrinsically disordered proteins  
Intrinsically disordered proteins (IDPs) lack a stable tertiary structure under physiological 
conditions and exist as ensembles of different conformational states. More than 30% of the 
proteome is thought to consist of IDPs [9] and intrinsically disordered regions (IDRs) are 
hyper-abundant in transcription factors and cell signaling proteins [5]. IDPs have challenged the 
dominant view of protein structure-function relationships. The following are some of the unique 
characteristics of intrinsically disordered regions (IDRs): high specificity for multiple targets due 
to structural plasticity, different conformations in the bound state depending on the binding 
partners, high specificity and relatively low binding affinity to binding partners, fast association 
and dissociation rates with binding partners [10], and enrichment with post-translational 
modification sites [11] and splicing isoforms [12]. All these attributes together make IDRs tunable 
and versatile for regulation of cellular functions.  
1.3 The interplay between allostery and intrinsic disorder manifested in EAM 
The coexistence of allostery and intrinsic disorder in regulatory proteins, such as cell 
signaling proteins and transcription factors, suggests that IDRs may play important roles in 
regulating allosteric coupling. Our group first entered this field by proposing a simple ensemble 
model [6] to study allosteric coupling. The model treated two or three tethered domains in an 
allosteric protein as being either folded (high affinity conformation to ligand) or unfolded (low 
affinity conformation to ligand), resulting in multiple states in the ensemble. Coupling between 
domains is expressed as interaction energy, which represents the statistical nature of the 
interaction. Depending on the energetic costs of interconverting between the folded state and 
unfolded state of each domain and of breaking the interaction between domains, each state in the 
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ensemble has a different probability. Effector binding stabilizes the high affinity state to effector 
and thus redistributes the ensemble. Allosteric coupling response is considered as the degree to 
which the probability of states in which functional sites are folded is affected for a given 
perturbation to states that can bind effectors. An unbiased and exhaustive search of parameter 
space found that allosteric coupling is maximized when the proteins contain ID domains and 
significant interaction energy between the two domains is a prerequisite for coupling [6]. More 
generally, allostery caused by different energetic perturbations (besides ligand binding) to the 
preexisting ensemble, such as post-translational modifications, mutations, and truncations can all 
be understood in terms of the EAM [6].  
1.4 Glucocorticoid receptor, an experimental system to investigate the interplay 
between intrinsic disorder and allostery from the ensemble view 
Glucocorticoid receptor (GR), a transcription factor in the steroid hormone receptor (SHR) 
family, plays key roles in organ development, metabolite homeostasis and the inflammatory 
response [13]. Malfunction of GR leads to cancer, metabolic diseases and inflammatory disorders 
[14], and GR-based pharmaceuticals are among the most commonly prescribed drugs. GR 
contains three major domains, the intrinsically disordered N-terminal domain (ID NTD), the DNA 
binding domain (DBD) and the ligand binding domain (LBD) [15]. Allostery is known to govern 
the function of SHRs [16, 17]. In GR, the intra-domain and inter-domain allosteric couplings are 
widely reported in the literature [18-22]. However, the mechanism is elusive, especially how the 
long NTD is involved in the coupling due to the difficulty of investigating it. The major 
transactivation region of GR, activation function 1 (AF1) region, which contains co-regulators’ 
binding sites, is located in the NTD [23, 24]. In addition the functional importance of GR’s NTD 
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is also suggested by the recently discovered eight human GR translational isoforms with different 
tissue distributions, different transcriptional activities and unique gene regulation sets [25]. 
Surprisingly, these translational isoforms differ only in the length of their NTD [25, 26] (as shown 
in Fig. 1). All of these led us to investigate whether and how the NTD is involved in the allosteric 
coupling network in GR. Truncation of the LBD removes GR’s transcriptional activity dependence 
on hormone and generates a constitutively active, two-domain construct [27] as shown in Fig. 1. 
The constitutively active constructs of different translational isoforms were used for functional 
assays in this thesis. 
1.5 Overview of thesis 
In Chapter 2, the osmolyte TMAO was used to induce folding transitions of the NTD of 
three representative translational isoforms, A, C2 and C3. It was found that the full length NTD 
can be viewed as having at least two thermodynamically coupled regions, a functional (F) domain, 
indispensable for GR transcriptional activity, and a regulatory (R) domain, whose length serves to 
regulate the activity of GR [26] (as shown in Fig. 1a). These two regions are unfavorably coupled 
to each other. 
Chapter 3 compares osmolyte induced folding transitions of the single NTD construct and 
the NTD-DBD two-domain constructs of the A and C3 isoforms. We found that DBD influences 
both the folding cooperativity and the energetics of the NTD. This suggested that the NTD and 
DBD were allosterically coupled to each other.  
In Chapter 4, binding affinities to GRE were measured for the eight translational isoforms. 
They show different binding affinities varying about 5 fold even though they have exactly the 
same DBD. This suggests that the ID NTD is allosterically coupled to DBD, and in different 
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translational isoforms, the coupling is differentially regulated. The binding affinities of the eight 
isoforms provide useful hints about the allosteric coupling mechanism between the ID NTD and 
DBD, and guided us to generate testable hypothesis in the functional assays.  
For Chapter 5, a dual luciferase reporter assay in a mammalian cell line, U-2 OS, was used 
to test the hypothesis generated from the biophysical studies. Dependence of transcription activity 
on GR vector dosage was measured for each translational isoform, and maximum transcriptional 
activity and relative binding strength to GRE of each isoform was fitted. In addition, a competitive 
transfection assay was designed and shown to be valuable for measuring the binding of inactive 
GR isoforms to the GRE. Transcriptional activity was tunable for the eight translational isoforms 
and did not correlate with the binding affinity to GRE. This observation was puzzling at first, 
because the binding of transcription factors to their response elements generally determines their 
specificity and activity [28, 29]. In the remaining part of this thesis, the detailed allosteric coupling 
mechanism was investigated to resolve this puzzling observation. 
In Chapter 6, the hypothesis that the R domain is favorably coupled to the DBD was further 
tested using the luciferase assay. Different parts of the R domain were directly linked to DBD 
through a flexible linker and the influence on DBD’s binding affinity to GRE was measured 
through the competitive transfection assay. The results supported the favorable coupling between 
the R domain and DBD. The thermodynamics of allostery in GR can be summarized based on the 
in vitro biophysical characterization and the cell based functional assay. Bidirectional competing 
energetic coupling is found to tune the transcriptional activities and binding affinities of different 
translational isoforms. 
In Chapter 7, the ensemble allosteric model (EAM) was built for eight GR translational 
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isoforms based on the experimental constraints. Reasonable thermodynamic parameter 
combinations could be found such that the simulated transcription activity and binding affinity are 
both significantly correlated with the experimental measurements. The lack of correlation between 
transcriptional activity and binding affinity of eight GR translational isoforms could also be 
captured by the EAM. 
Mutagenesis is commonly used to probe which residues are involved in an allosteric 
coupling network. However, in complicated systems, the mutational effects are difficult to 
interpret. Based on the EAM model we constructed for GR, the influence on transcriptional 
activity and binding affinity upon mutagenesis can be predicted for different scenarios. This is 
discussed in Chapter 8, and paves a way for pinpointing the molecular basis of allostery in GR. 
Chapter 9 describes how the molecular basis of allostery between the R and F domains was 
investigated by site directed mutagenesis in luciferase activity assays, and some residues involved 
in the coupling network were found. 
In Chapter 10, we explored the coupling mechanism between the F domain and DBD. Point 
mutations and chimeric constructs of the C3 isoform were tested using the luciferase activity assay. 
All the results support that there is favorable coupling between the F domain and DBD, and the 
molecular basis for the coupling was interpreted from these experiments. 
In Chapter 11, to investigate the molecular basis of allostery between the R domain and 
DBD, single point mutations were introduced to the DBD construct and a construct with the R 
domain conjoined with the DBD. Interpreting mutational effects based on EAM predictions 
helped us to pinpoint the coupling mechanism. 
In Chapter 12, the importance and possible application of the research is discussed.   
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Figure 1 | Domain architecture (top) and organization (bottom) of the eight, two-domain 
glucocorticoid receptor isoforms.  
Human glucocorticoid receptor (GR) constructs that are constitutively active are composed of the 
intrinsically disordered N-terminal domain (NTD) (1-420), and the DNA binding domain (DBD) 
(421-486), as well as part of hinge region (487-525), is shown as cartoon. The NTD is subdivided 
into the regulatory (R) domain and functional (F) domain, There are 8 translational isoforms, A, B, 
C1, C2, C3, D1, D2 and D3 with differing lengths of their NTD. The lower part of the graph 
systematically shows the starting sites of the isoforms labeled according to their position in the 









Chapter 2- Thermodynamic Dissection of the Intrinsically Disordered 
N-terminal Domain of Human Glucocorticoid Receptor 
2.1 Abstract 
Intrinsically disordered (ID) regions are abundant in cell signaling proteins and 
transcription factors. As ID regions commonly fold up during intracellular function, it is crucial to 
understand these folded states and how they affect the overall function of the parent protein. In 
this part, we thermodynamically characterized the intrinsically disordered ID N-terminal domains 
(NTD) of three glucocorticoid receptor (GR) translational isoforms by using the osmolyte 
trimethylamine N-oxide (TMAO) to induce folding transitions. All the three investigated NTD 
isoforms were found to be cooperatively foldable to globular protein-like conformers in TMAO. 
In addition, the full length NTD was found to contain at least two functionally distinct regions, the 
regulatory (R) domain and the functional (F) domain, which are negatively coupled to each other. 
Remarkably, adjusting the length of R (as observed in naturally occurring isoforms), turned out to 
regulate the stability of the NTD. This suggests that regulating the stability of ID regions could be 
used as a paradigm for regulating the function of ID proteins. 
2.2 Introduction 
The classical view of protein structure-function relationships, the protein structure defines 
its function, has been challenged by the increasing number of proteins found to contain ID regions, 
particularly cell signaling proteins and transcription factors [5, 30, 31]. Many of these ID regions 
are found to contain abundant binding sites for important protein partners [30, 32-34], and folding 
coupled with binding usually happens when these ID regions encounter their binding partners [30, 
32-34]. Thus in most cases, the conditionally folded states are the functional states of ID proteins. 
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Mutagenesis [35], truncation or translocation of ID regions in some proteins [32] is usually 
involved in diseases. However, largely unknown are the mechanisms by which these changes in 
ID regions regulate protein functions. Osmolyte induced folding of some ID proteins has been 
reported and the induced folded states were determined to be functionally relevant [36, 37]. This 
provides a way to study the folded state of ID proteins. However, the folding cooperativity, judged 
by m-value in osmolyte induced folding [38], is poorly characterized. Amino acid usage in ID 
proteins is significantly different from that in globular proteins [31]. Whether the thermodynamic 
ground rules governing globular proteins can be used in studying ID proteins is not clear. 
 To better understand proteins containing ID regions, we carried out thermodynamic 
characterization of the ID N-terminal domains (NTD) of three human GR translational isoforms. 
The NTDs for SHRs are extremely important for transcriptional regulation, serving as a hub to 
recruit co-regulators to form the final transcriptional complex [13, 24, 39]. The 
“hormone-independent” transactivation domains AF1 have been mapped within each SHR NTD 
by deletion, insertional mutation or point mutagenesis analysis [24]. In human GR, AF1 is mapped 
onto residues 77-262 [40] (as shown in Fig. 2).  Recently, different human GR N-terminal 
translational isoforms with differing activities, tissue distributions and unique gene regulation sets 
were reported to be generated from one single GR mRNA through translational regulatory 
mechanisms [25]. These translational isoforms only differ in the length of their NTDs (as shown 
in Fig. 1 and Fig. 2). Except for the isoforms (D1, D2 and D3) that do not overlap any part of the 
AF1 transactivation domain, these isoforms are all active and have different potencies in 
transcriptional regulation [25]. Especially intriguing was how the activity is highly sensitive with 
as little as eight amino acid differences in the ID domain (i.e. the length difference between C2 
 10 
and C3 isoforms) playing a key role in functional regulation. We carried out the study of human 
GR using the A (amino acid 1-420), C2 (90-420), and C3 (98-420) isoforms. 
To access the folded conformations of these ID proteins, the naturally occurring osmolyte 
trimethylamine N-oxide (TMAO) was employed to induce the folding transitions. Organic 
osmolytes are small molecules in cells and function to stabilize and protect intracellular proteins 
against common denaturing environmental stresses [41, 42]. TMAO has been demonstrated to 
force thermodynamically unstable proteins to fold and regain high functional activities [18, 36, 
43].  
In this chapter, we report a novel strategy to express and purify the long ID GR NTD in E. 
coli, enabling measurement of the cooperative folding transitions of GR NTDs to globular 
protein-like folded conformations when induced by TMAO. The results demonstrate that GR NTD 
contains at least two thermodynamically distinct regions, the “regulatory (R) domain” and the 
“functional (F) domain”, which are unfavorably coupled to each other.  
2.3 Materials and methods 
Protein expression, purification and storage  
Coding sequences to express GR A-NTD, GR C2-NTD and GR C3-NTD with 10 tandem 
histidines tagged on both N and C termini were optimized for E. coli expression and synthesized 
by DNA 2.0 (Menlo Park, CA), and inserted into the pJ411 bacterial expression vector under T7 
promoter control. BL21(DE3)pLysS competent cells (Novagen) transformed with expression 
plasmids were plated on LB plates with 30ug/mL kanamycin and incubated at 37°C overnight. A 
single colony was picked up and inoculated into 50 mL LB medium with 30ug/mL kanamycin and 
grown in 30°C incubator shaker at 250 rpm overnight. The following morning, each 10mL 
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overnight culture was transferred to 500mL LB medium and grown at 37°C to OD600 0.8, then 
the temperature was adjusted to 15°C. After 1 hour, the culture was induced by 1 mM 
isopropyl-β-D-thiogalactopyranoside (IPTG). After 18 hours at 15°C with shaking at 250rpm, E. 
coli cells were collected by centrifugation for 15min at 5000 rpm at 4 °C and pellets were washed 
with phosphate buffered saline (PBS) and centrifuged again. To cell pellets from 2 L culture, 50 
mL denaturing lysis buffer (6M guanidine hydrochloride, 100mM monosodium phosphate, 10mM 
Tris, 20mM imidazole, pH 8.0) and one cOmplete- EDTA-free ® protease inhibitor cocktail tablet 
(Roche) were added.  Cells were lysed by flash freezing for 20 min twice in a dry ice and ethanol 
mixture and thawing for 10 min in 42°C water bath twice. Cell lysate was centrifuged at 30,000g 
at 4 °C for 1 hour. The supernatant from 4 L induced cells was loaded onto LPLC column packed 
with 20 mL Ni-NTA superflow resin (Qiagen) pre-equilibrated with the denaturing lysis buffer by 
gravity flow. After thoroughly washing the column with the denaturing lysis buffer at 2 mL/min, 
protein was renatured on the column by flowing native lysis buffer (100mM monosodium 
phosphate, 10mM Tris, 20mM imidazole, pH 8.0). Afterwards, native lysis buffer containing 
200mM imidazole was applied to the column at 2 mL/min, to wash out the contaminants and 
degradation products with His-tag only on one terminus. Finally, target protein was eluted from 
the column by native lysis buffer containing 500mM imidazole. Protein purity was checked on 
SDS-PAGE. The purified target protein was dialyzed against storage buffer containing 10mM 
HEPES, 80mM NaCl, 1mM EDTA and 10% glycerol, pH 7.6. Protein concentration was then 
determined by the absorbance at 280 nm in the UV spectrometer according to the Edelhoch 
method [44]. Each 500uL protein aliquot in 1.5 mL Protein Lobind Tube (Eppendorf) was then 
flash frozen in an ethanol- dry ice bath and stored at -80°C. 
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Preparation of Trimethylamine N-oxide (TMAO) buffers  
Trimethylamine-N-oxide Dihydrate (TMAO, 98% pure, Acros Organics) was dissolved in 
100mM Tris, 200mM NaCl, 50mM Arginine buffer to make the 0M, 0.5M, 1M, 1.5M, 2M and 
2.5M TMAO buffers. pH was adjusted to 7.4 for each buffer separately. Activated carbon, 12-20 
mesh (Sigma-Aldrich) was added into each buffer solution and stirred for 30min while protected 
from light to absorb the impurities. The buffer was then filtered (0.22um filter, Millipore), 
aliquoted, and stored at -80°C. TMAO buffers with similar concentrations were mixed to obtain 
the target TMAO concentration used in the following fluorescence measurements, minimizing the 
pH changes due to mixing two TMAO buffers with equal pH but large concentration difference. 
Arginine, which is reported to aid protein solubility [45], was included in the TMAO buffers at a 
concentration of 50mM and efficiently prevented protein aggregation.  
TMAO induced protein folding transition monitored by tryptophan emission fluorescence 
intensity  
Fluorescence emission spectra for each purified recombinant GR NTD construct were 
measured using an Aviv ATF 105 fluorometer (Aviv Biomedical) in TMAO buffers of varying 
concentrations. Freshly prepared dithiothreitol 1 M stock solution was added to TMAO buffer to a 
final concentration of 1 mM. Protein at 0.5 μM in a volume of 150 μL TMAO buffer at 22°C was 
allowed to rest in a “sub micro” fluorometer cell (Santa Cells) for 5 minutes to allow for 
temperature stabilization and protein conformational equilibrium to be reached. Emission spectra 
were then recorded with excitation at 295nm. All spectra were corrected for the contribution of its 
corresponding buffer.  
Fluorescence emission intensities at 338nm were recorded as a function of TMAO 
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concentration and normalized to the intensity at 0M TMAO concentration. The resulting sigmoid 
curve was fitted to a two-state cooperative folding transition with linear extrapolation method 
(LEM, [46]) to determine the stability (∆GU→F) and m-value for each construct. The LEM method 
has been shown to be valid for fitting the data of osmolyte induced folding of ID proteins [47]. 
Protease protection assay 
Protease digestions of purified GR A-NTD, GR C2-NTD and GR C3-NTD proteins at 1 
mg/mL were performed with sequencing grade trypsin (Sigma) at 22˚C. Digestions were 
performed at a protein versus trypsin mass ratio of 1000:1 in 10 mM HEPES, 80 mM NaCl, 1 mM 
EDTA and 10% glycerol buffer, pH 7.6 for 0 min, 5 min, 10 min and 30 min. Digestions were 
quenched by mixing protein and trypsin mixtures with 6x Laemmli sample buffer and boiling at 
100°C for 10min. 40 μg of sample at each time point was separated on 4-15%, SDS-PAGE gels 
(Bio-Rad) with SDS-Tris-Glycine gel running buffer. 
2.4 Results and discussion 
Expression and purification of GR NTDs in E. coli 
Expression and purification of GR A-NTD, GR C2-NTD and GR C3-NTD constructs were 
carried out in E. coli. As degradation and low yield are general problems in expression and 
purification of recombinant ID proteins from E. coli, I used the following: engineered plasmids 
with optimized codons for E. coli (DNA2.0), affinity purification tags on both the N terminus and 
C terminus of each construct, a protease deficient competent expression strain (BL21(DE3)pLysS), 
overnight protein expression at low temperature (15°C), mild flash freezing and thawing to lyse 
cells, purification under denatured conditions and renaturing protein on Ni-NTA column,  and 
protease inhibitor cocktail (Roche). These strategies, as described in Materials and Methods, gave 
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reasonable yields of about 10 mg purified protein per liter E. coli cells and significantly countered 
degradation during expression and purification, as shown under the 0 min trypsin digestion lanes 
for each construct (Fig.4).  
The naturally occurring osmolyte TMAO can induce cooperative folding transitions in the 
NTDs of different GR translational isoforms 
With excitation at 295nm, tryptophan emission spectra were measured for GR’s A-NTD, 
C2-NTD and C3-NTD in buffers with different TMAO concentrations. All three constructs 
contain two tryptophans corresponding to the tryptophans in full length NTD at residues 213 and 
364. As shown in Fig. 3 inset, in absence of TMAO, the maximal emission wavelength is at 348 
nm with excitation at 295 nm for GR A-NTD construct (the same case was observed for GR 
C2-NTD and GR C3-NTD constructs, data not shown), indicating the tryptophans are solvent 
exposed in these ID proteins. In presence of 2.2 M TMAO, the emission wavelength maxima 
show a significant blue shift (338 nm versus 348 nm, see Fig.3), indicating that TMAO induced a 
more ordered conformation in these disordered proteins. Fluorescence intensities at 338 nm as a 
function of TMAO concentration for each construct were fitted successfully to the cooperative 
two-state transition model using LEM [46] as shown in Fig. 3. Free energies, ∆GU→F, representing 
the stability of the folded state with unfolded state as reference, were fitted to be 10.1±0.9, 8.9±0.4 
and 7.6±0.4 kcal/mol for GR’s A-NTD, C2-NTD and C3-NTD, respectively.  M-values, 
representing the cooperativity of the transitions, were fitted to be 8.8±0.4, 6.9±0.4 and 6.7±0.3 
kcal/ (mol*M) for GR A-NTD, GR C2-NTD and GR C3-NTD, respectively (as shown in Table 1).  
Protease protection assay validates the rank order of stability estimates from TMAO folding of 
the GR A-NTD, GR C2-NTD, and GR C3-NTD constructs 
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The stability measurements obtained from TMAO-induced folding provided an estimate of 
the stability of the folded state. To determine whether the apparent free energies from Table 1 are 
reporting on the relative stabilities of the unfolded proteins in the absence of TMAO, limited 
trypsin digestions of GR’s A-NTD, C2-NTD, and C3-NTD were performed (as shown in Fig. 4). 
One hallmark of ID proteins is their high inherent sensitivity to protease digestion [48]. As 
expected, all three constructs are highly sensitive to trypsin. With a protein versus trypsin mass 
ratio 1000:1 at 22˚C, after 5min, significant degradation could be observed for all constructs, and 
after 30 min, all approached complete digestion. Comparing the protease sensitivity, the A-NTD is 
the most sensitive while C3-NTD is the most stable. This observation is consistent with the 
stabilities of these constructs extrapolated from TMAO folding experiments, GR C3-NTD is ~1.3 
kcal/mol more stable than C2-NTD, and ~2.5 kcal/mol more stable than A-NTD. Both the 
extrapolated free energy values and sensitivities to trypsin digestion for A-NTD, C2-NTD and 
C3-NTD indicate that truncation of the N-terminus of GR stabilize this ID domain.  
The folded states of GR NTDs induced by TMAO are thermodynamically similar to globular 
proteins of similar length 
One important thermodynamic parameter from the application of LEM [46] to osmolyte 
induced protein folding is the m-value, which is defined as follows [46]: 
. The m-value, which has the unit of kcal/(mol*M), 
represents the molar efficacy of osmolyte in folding a protein, and also measures the cooperativity 
of the transition between the unfolded and folded state [49].  For a cooperative two-state 
transition induced by a particular osmolyte, the m-value is proportional to the surface area buried 






relationship between m-values and globular protein chain lengths have been reported for 
denaturant induced protein unfolding [50].  In Fig. 5, the reported m-values between the fully 
unfolded and fully folded states for TMAO folding, Barstar [51], RCAM-T1 [37] , P protein [52] 
and Nank1-7 [53], are shown as a function of protein length. For comparison, m-values of TMAO 
induced folding of GR A-NTD, GR C2-NTD and GR C3-NTD determined in this study are also 
depicted. These seven data points could be fitted to a line with correlation coefficient R
2
=0.97. 
Two illustrations can be pointed out from this observation. First, it indicates that GR’s A-NTD, 
C2-NTD and C3-NTD undergo cooperative transitions with increasing TMAO concentration, only 
the fully unfolded state and the fully folded state are populated during the transition. Second, the 
m-values for the long GR N-terminal domains and m-values for the globular proteins Barstar, 
RCAM-T1, P protein, Nank 1-7, (which are in the unfolded state under physiological conditions 
by destabilizing mutations) could be linearly fitted, demonstrating that full-length NTD and the 
two truncated translational isoforms are able to adopt native folds that are thermodynamically 
similar in terms of surface area burial to those adopted by globular protein. However, although 
seemingly unlikely, we cannot exclude the possibility that both the folded and unfolded states of 
ID and globular proteins are different from each other and respond differently to TMAO but that 
the differences are quantitatively canceled out in the overall m-value. 
Full length GR NTD contains at least two thermodynamically coupled regions  
The transactivation domain AF1,which is mapped to residues 77-262 within NTD in human 
GR, is indispensable for its maximal transcriptional activity [40]. However, the roles of the otheR 
domains in the NTD are not clear. As the activities of GR isoforms are acutely affected by 
truncation from the N terminus of AF1 [25], it suggests that the fragment containing the first 97 
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amino acids in the GR NTD acts as a “regulatory (R) domain or domain”. To check whether the R 
and F domains are coupled to each other, an ensemble allosteric model (EAM) [6] was constructed 
for the full length GR NTD considering that it is composed of R and F domains (as shown in Fig. 
6). To quantify the effect, we needed to obtain estimates of the intrinsic stabilities and interaction 
energies (i.e., ∆GR, ∆GF and ∆gint). We note that the stability of the F domain can be directly 
obtained from the TMAO-induced folding of the C3 construct, ∆GF = -∆G
0
U→F (GR C3-NTD) = 
-7.6 kcal/mol. Determination of the stability of the R domain is less straightforward.  The small 
size (97 a.a.) and the lack of Trp residues in this region make it impossible to observe and 
thermodynamically characterize with TMAO (as done with the F domain). Nonetheless, the CD 
signal of the GR1-97 construct (in the absence of TMAO) provides an important clue about the 
range of possible stabilities of the R domain. 
As shown in Fig. 7, the relative CD signals at 200 and 222 nm for the GR 1-97 construct 
places it somewhere between the average signal for folded and ID proteins [54, 55].  This 
suggests that both folded and unfolded states must be populated to a significant degree.  As only 
a narrow range of stability allows for both folded and unfolded species to co-exist in substantial 
quantities simultaneously (i.e., ~-1.5 < ∆GR < ~1.5 kcal/mol), to a first approximation the folded 
and unfolded states can be estimated to be equally probable (i.e, ∆GR~ 0 kcal/mol). Using these 
estimates for the stabilities of the F and R domains (i.e., ∆GF= -7.6 kcal/mol and ∆GR= 0 kcal/mol 
are fixed), the data for the TMAO dependence of the fluorescence of GR A-NTD can be fitted to 
obtain an estimate of the interaction energy. 
The fitted value of ∆gint in the absence of TMAO (∆g
o
int = -3.0 ± 1.0 kcal/mol) indicates 
that the F and R domains are negatively coupled, and that the parameters are able to accurately 
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reproduce both the GR A-NTD and GR C3-NTD TMAO refolding curves (Fig. 8). We also note 
that the results are not qualitatively sensitive to the precise value of ∆GR; systematically varying 
the magnitude between -1.0 and +1.5 kcal/mol nonetheless results in a negative ∆gint.  
2.5 Conclusions 
In conclusion, long NTDs in three GR translational isoforms were found to cooperatively 
fold into globular protein-like folded states in the presence of TMAO. The 420 amino acid long 
NTD of GR contains at least two thermodynamically distinct regions, the regulatory (R) domain 
and the functional (F) domain, which are negatively coupled to each other. This negative coupling 












Figure 2 | Schematic representation of the GR’s NTD sequence showing the positions of 
different GR translational isoform start sites.  
The three constructs, A-NTD, C2-NTD and C3-NTD, which are thermodynamically characterized 
















Figure 3 | TMAO-induced conformational transitions of GR A-NTD, C2-NTD, and C3-NTD 
monitored by tryptophan emission fluorescence intensity. 
TMAO-induced conformational transitions of GR A-NTD (open squares), C2-NTD (open circles), 
and C3-NTD (open triangles) monitored by tryptophan emission fluorescence intensity at 338 nm 
with excitation at 295 nm. Fluorescence emission intensity at each TMAO concentration was 
normalized to that at 0 M TMAO concentration. The folding experiments were performed at 22 °C 
with a protein concentration of 0.5 μM. Nonlinear least square fits to two-state transitions using 
the linear extrapolation method were carried out for each construct (solid line). The best-fit 
thermodynamic parameters are shown in Table 1. Inset, GR A-NTD fluorescence emission 
spectrum with excitation at 295nm in 0 M TMAO with λmax at 348nm (solid line) and in 2.2 M 









Figure 4 | Protease protection assays for GR A-NTD, C2-NTD, and C3-NTD.  
Trypsin digestions were performed at a protein (1 mg/ml):trypsin mass ratio of 1000:1 at 22 °C in 
10 mM HEPES, 80 mM NaCl, 1 mM EDTA, 10% glycerol buffer, pH 7.6 for 0, 5, 10, and 30 min. 
After quenching, 45 μg samples from each time point were separated on 4–15% SDS-PAGE gels 













Figure 5 | Dependence of m-values on protein chain length (L) for TMAO induced folding 
transitions.  
Shown are the m-values fitted from TMAO-induced two-state folding transitions for Barstar 
(closed star 1), RCAM-T1 (closed star 2), P protein (closed star 3), Nank 1–7 (closed star 4), GR’s 
A-NTD (open square), C2-NTD (open circle), and C3-NTD (open triangle). All seven data points 
can be well fit to a line; i.e. m-value = 0.0215*L with a correlation coefficient of R
2
 = 0.97. This 
indicates that the TMAO-induced folding of GR A-NTD, C2-NTD, and C3-NTD followed a 
cooperatively two-state transition process. In addition, the folded states of GR NTDs induced by 











Figure 6 | Schematic representation of the ensemble allosteric model of full-length GR NTD 
containing the R domain and F domain. 
Each region can be folded or unfolded, resulting in four possible states (i.e., N, I1, I2 and U). S.W. 
is the statistical weight for each state, and Q is the partition for the system, which is the sum of the 
















Figure 7 | Circular dichroism data comparison for globular and ID protein in terms of Δε222 
nm versus Δε220 nm 
Open triangles represent the data from the Protein Circular Dichroism Data Bank [54, 55], and 
open circles represent the data for disordered protein [54, 55] . The filled star, triangle, and circle 
represent the data for GR A-NTD, C2-NTD, and C3-NTD, respectively, measured in this study. 
The filled square represents the data for GR 1–97, which is midway between the clusters for ID 
and globular folded proteins. deg, degrees. This supports the conclusion that the R domain in 









Figure 8 | Dependence of the population of the states with F domain folded on TMAO 
concentration for A-NTD and C3-NTD.  
Raw data for GR A-NTD (open squares) and C3-NTD (open triangles) are calculated from the 
TMAO folding curve as shown in Fig. 3. The underlying assumption made is that the fully 
unfolded state U and the intermediate state I1 (where the F domain is unfolded) have the same 
fluorescence emission intensity (set to 0) and that the fully folded state N and the intermediate 
state I2 (wherein the F domain is folded) have the same fluorescence emission intensity (set to 1) 
as both of the two NTD tryptophans are in the F domain. The fitted curve is based on the linear 
extrapolation method, fitting to the equation that observable equals the sum the probability of the 
N state and I2 state as shown in Fig. 6. The fitted parameters are as follows: ∆G
0
F→U (F) =-8.4±0.5 
kcal/mol, m (F) = 7.4±0.4 kcal/(mol*M); ∆G
0
F→U(R) =0 kcal/mol, m (R) = 2.1±0.4  
kcal/(mol*M); ∆g
0










Table1. Fitting parameters for GR A-NTD, GR C2-NTD and GR C3-NTD constructs from 
TMAO induced folding transitions. 
 
Constructs ∆G U→F (kcal/mol) m-value (kcal/(mol*M)) 
GR A-NTD 10.1±0.5 8.8±0.4 
GR C2-NTD 8.9±0.4 6.9±0.3 



















Chapter 3- Thermodynamic Dissection of the NTD and DBD 
Two-domain Constructs of Human Glucocorticoid Receptor 
3.1 Abstract 
The existence of inter-domain allosteric coupling between NTD and DBD in GR has been 
reported in the literature; however, there is no reported quantitative investigation. As TMAO 
induced folding transitions can be used to quantify the thermodynamic parameters of the NTD of 
GR isoforms as discussed in Chapter 2, we also carried out these folding experiments on the GR 
A-NTDDBD and C3-NTDDBD constructs. These studies were aimed at quantifying the 
thermodynamic coupling between the domains. As expected, these two-domain constructs were 
also foldable using TMAO.  
However, judging from the m-value, which provides insight into the protein 
folding/unfolding cooperativity, GR A-NTDDBD (composed of R, F and DBD as shown in Fig. 1) 
did not follow a cooperative, two-state folding transition and only C3-NTDDBD (composed of F 
and DBD as shown in Fig. 1) obeyed the cooperative, two-state folding transition. Comparing the 
stability extrapolated for C3-NTD and C3-NTDDBD constructs, we found that the NTD of C3 
was stabilized in presence of DBD. This indicates there is favorable coupling between the F 
domain in the ID NTD and the DBD.  
3.2 Introduction 
One characteristic of proteins in the SHR family is their domain architecture. Most of the 
members contain three major domains, the intrinsically disordered N-terminal domain (NTD), the 
DNA binding domain (DBD) and the ligand binding domain (LBD) [15]. The LBD contains a 
binding site for hormones, the DBD contains a binding site for the hormone response element 
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(HRE), and the NTD contains the major transactivation region, AF1, which is the binding site for 
most co-regulators. Coupled folding and binding have been suggested to be the key for the 
interaction of the NTD and its co-regulators [15]. Clearly, linking multiple domains with different 
functions in steroid hormone receptors make them work as hormone dependent nuclear 
transcription factors, as they are only functional in the complex with hormone, HRE and 
co-regulators bound. Except for executing their individual functions, do individual domains also 
communicate with neighboring domains and influence each other’s functions?  The strategy to 
dig into the biophysical origins of the functional communications is to ask whether neighboring 
domains influence each other’s thermodynamics or folding kinetics [56].  
In GR, the inter-domain allosteric coupling between NTD and DBD has been reported in 
the literature [18, 19, 22]. For instance, R.Kumar and colleagues found that binding of DBD to the 
GR response element (GRE), the DNA sequence that could bind to the DBD, induced additional 
structure in the NTD [18]. In addition, Yamamoto’s group found that mutations within the 
activation function 1 (AF1) region in NTD exhibited different influences on GR transcriptional 
activity when bound to different GRE [19]. These two examples demonstrate that there is 
significant energetic coupling between GR NTD and DBD, and this coupling influences GR’s 
function as a transcription factor. However, so far there is no reasonable quantification of the 
allosteric coupling.  
To further study the inter-domain coupling between NTD and DBD, we carried out TMAO 
induced folding transitions on GR two-domain constructs containing NTD and DBD. As expected, 
the folding transitions of both GR A-NTD and C3-NTD are influenced by the presence of DBD. 
Specifically, GR A-NTDDBD construct, composed of R domain, F domain and DBD, did not 
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follow cooperative two-state transitions. GR C3-NTDDBD construct, composed of F and DBD, 
turned out to follow cooperative two-state transitions. And the fitted parameter suggested that the 
F domain is stabilized in the presence of the DBD. In both cases, DBD influences the folding of its 
neighboring NTD, which suggests that there are domain interfaces between the folded state of 
NTD and DBD [56].  
3.3 Materials and methods 
Plasmids 
Codons encoding human GR A-NTDDBD were optimized for E. coli expression with 6 
histidines tagged on the N terminus and synthesized by DNA 2.0 (Menlo Park, CA), and inserted 
into the PJ411 bacterial cell expression vector under T7 promoter control. Plasmid 
PJ411-C3-NTDDBD was made by inserting the codons for C3-NTDDBD amplified from PJ411 
A-NTDDBD into the NdeI and XhoI sites of the PJ411 vector. 
Protein expression, purification and storage 
Protocols for expression, purification and storage of the two-domain constructs were the 
same as the protocols for the single N terminal domain construct as described in chapter 2, except 
for the following modifications in the purification steps on Ni affinity column. The lysis buffer is 
composed of 100mM monosodium phosphate, 10mM Tris, 500mM NaCl, 20mM imidazole, pH 
8.0. The wash buffer is the lysis buffer containing 60mM imidazole and the elution buffer is the 
lysis buffer containing 200mM imidazole.  
Osmolyte TMAO induced protein folding transitions 
Protocol for TMAO induced folding transitions is the same as described in chapter 2.  
Protease protection assay 
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The protease protection assay was carried out in the same way as done for the single NTD 
constructs as describe in chapter 2, except for the following modification. The protein and trypsin 
ratio was 500:1 instead of 1000:1 in single NTD constructs’ digestion. 
3.4 Results and discussion 
TMAO induced folding of GR A-NTDDBD construct does not follow cooperative two-state 
transition 
Tryptophan emission spectra were measured for GR A-NTDDBD construct in buffers with 
different TMAO concentrations with excitation at 295nm. The construct contains two tryptophans 
corresponding to the tryptophans in full length NTD at residues 213 and 364. As shown in Fig. 9, 
in absence of TMAO, the maximal emission wavelength was at 348nm for GR A-NTDDBD 
construct, indicating the tryptophans are solvent exposed in this ID region. In the presence of 
2.5M TMAO, the emission wavelength maximum shows a significant blue shift (338nm versus 
348nm), indicating that TMAO induced a more ordered conformation in this disordered protein. 
As the sigmoid curve was observed, normalized fluorescence intensities at 338nm were fitted to 
the cooperative two-state transition model using LEM [46] as shown in Fig. 10. Free energy, 
∆GU→F, representing the stability of the folded state with unfolded state as a reference, was fitted 
to be 5.7 kcal/mol for GR A-NTDDBD.  The m-value, representing the cooperativity of the 
transition, was fitted to be 4.9 kcal/(mol*M) as listed in Table 2. Noticeably from Fig. 10, the 
slope of the A-NTDDBD folding transition is less than that for the A-NTD construct. As 
A-NTDDBD and A-NTD constructs have the same length of the intrinsically disordered NTD 
(420 amino acids), and both of the two tryptophans monitored in the fluorescence spectrum are in 
the NTD, the significantly different folding transitions between A-NTDDBD and A-NTD indicate 
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that DBD influences NTD’s folding properties. As shown in Fig. 2 and discussed in chapter 2, 
A-NTDDBD construct is composed of the R domain, F domain and DBD. Thus there may be 
some interaction interface either between the R domain and DBD, or between the F domain and 
DBD, or both of these cases. 
If mapping the m-value for the A-NTDDBD construct to the graph of protein chain length 
and expected m-value, as shown in Fig. 12 we can see that the m-value for A-NTDDBD is much 
smaller than expected for the 420aa long construct following two-state folding transition in 
TMAO. This indicates that GR A-NTDDBD does not follow a cooperative two-state transition, 
and there may be some intermediate states populated during the transition, even though a sigmoid 
curve was observed. So the free energy fitted is the apparent free energy of the unfolded to folded 
transition, it does not truly represent the free energy difference between the folded and unfolded 
state. 
TMAO could induce cooperative folding transitions in C3-NTDDBD construct and the folded 
conformation of its ID part is stabilized in presence of DBD 
As done for A-NTDDBD, the C3-NTDDBD emission spectrum was also recorded with 
excitation at 295nm under different TMAO concentrations. Similarly, the emission wavelength 
maximum showed a significant blue shift with increasing TMAO concentrations, which indicated 
that the construct adopted a more compact conformation in TMAO. Emission intensity at 338nm 
was recorded as a function of TMAO concentration, and the distance to the two baselines was 
plotted as a function of TMAO concentration as shown in Fig. 11. This folding curve was fitted to 
the cooperative two-state transition model using LEM [46]. Free energy, ∆GU→F, representing the 
stability of the folded state with the unfolded state as reference, was fitted to be 6.7 ± 0.4 kcal/mol 
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for GR C3-NTDDBD. The m-value was fitted to be 7.0 ± 0.5kcal/ (mol*M) as listed in Table 2. 
If mapping the m-value for the C3-NTDDBD construct to the relationship between protein 
chain length and the expected m-value curve for the cooperative two-state transition as shown in 
Figure 11, we can see that the m-value for C3-NTDDBD is only a little bit larger than the 
expected m-value for C3-NTD. This indicates that GR C3-NTDDBD (composed of the F domain 
and DBD) probably follows a cooperative two-state transition in TMAO. And the interaction 
interface between folded conformation of F and DBD contributes some to the m-value. The fitted 
free energy, ∆GU→F, can be deconvoluted to the free energy difference between the folded state 
and unfolded state of the F domain, plus the free energy difference between the low affinity state 
and high affinity state of DBD to GRE, and the interaction energy between F domain and DBD. 
The derived equations are shown below with the folded state as a reference: 
∆GF→U = - ∆GU→F = ∆GF→U (F) + ∆GH→L (DBD) + ∆gint (F, DBD) = - 6.7 kcal/mol 
Where ∆GF→U (F) = -7.6 kcal/mol, extrapolated from the TMAO induced folding transition of the 
C3-NTD construct in Chapter 2, so ∆gint (F, DBD) = 0.9 - ∆GH→L (DBD). Comparing the DBD’s 
crystal structure in presence of GRE to its NMR solution structure in absence of GRE, the second 
and third helices are stabilized upon GRE binding. This suggests that in solution the more 
favorable state for DBD is the low affinity state, thus ∆GH→L (DBD) < 0. Consequently, ∆gint (F, 
DBD) = 0.9 - ∆GH→L (DBD) >0. This indicates that there is a favorable interaction between the 
folded conformation of the F domain and the DBD.  
Protease Protection Assay suggests allosteric coupling between R domain and DBD 
The protease protection assay was also carried out for GR A-NTDDBD construct and GR 
C3-NTDDBD construct at 22˚C with a protein vs trypsin ratio of 500 vs 1. As shown in Fig. 13, 
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GR’s A-NTDDBD is significantly protected from trypsin digestion compared to C3-NTDDBD 
and A-NTD, as shown in Fig. 4. This suggests that there may be a significant interaction between 
the R domain and DBD, and this interaction protects the NTD from protease digestion. This 
hypothesis will be further tested in the following chapters. 
3.5 Conclusions 
GR A-NTDDBD, composed of the R domain, F domain and DBD, did not follow a 
cooperative, two-state transition in TMAO. GR C3-NTDDBD, composed of the F domain and 
DBD, followed a cooperative, two-state transition in TMAO. The folded conformation of the F 
domain is stabilized in the presence of the DBD, which suggests there is favorable interaction 
energy between the F domain and DBD. Moreover, the protease protection assay comparing GR 
A-NTDDBD, C3-NTDDBD and A-NTD suggested that there may be some interaction between 












Figure 9 | Fluorescence emission spectrum of GR A-NTDDBD at 0M TMAO vs. 2.5 M 
TMAO. 
At 0 M TMAO the emission spectrum maximum wavelength was at 348nm, and 2.5 M TMAO it 
was blue shifted to 338nm. The blue shift suggests that the ID region adopted a more ordered 








Figure 10 | Comparison of TMAO-induced conformational transitions of GR A-NTDDBD 
and GR A-NTD monitored by tryptophan emission fluorescence intensity. 
TMAO was used to fold GR’s A-NTDDBD and A-NTD, monitored by tryptophan emission 
intensity with excitation at 295nm. Fluorescence intensity at 338nm was converted to the folded 
state probability, by calculating the distance of the raw signal to the unfolded and folded state 
baseline. The curve shown is the raw data fitted with LEM [46]. The best fit thermodynamic 





Figure 11 | TMAO-induced conformational transitions of GR C3-NTDDBD and GR C3-NTD 
monitored by tryptophan emission fluorescence intensity. 
TMAO was used to fold GR’s C3-NTDDBD and C3-NTD, monitored by tryptophan emission 
intensity with excitation at 295nm. Fluorescence intensity at 338nm was converted to the folded 
state probability, by calculating the distance of the raw signal to the unfolded and folded state 
baseline.. The curve shown is the raw data fitted with LEM [46]. The best fit thermodynamic 





















Figure 12 | Mapping m-value for GR A-NTDDBD and GR C3-NTDDBD on the m-value 
versus protein chain length chart.  
The m-value for GR A-NTDDBD significantly deviates from the expected value for a protein of 
that chain length, indicating GR A-NTDDBD doesn’t follow a two-state folding transition in 
TMAO. The m-value fitted from a two-state folding transition for GR C3-NTDDBD is a little bit 
larger than the expected value for the protein of that chain length, which is reasonable as there 
may be some interaction interface between the N terminal domain and DNA binding domain 
contributing to the m-value. Symbols are identical to those in Fig.5, except for the filled red circle, 




Figure 13 | Protease protection assays for GR A-NTDDBD and GR C3-NTDDBD.  
Trypsin digestions were performed at a protein (1 mg/ml): trypsin mass ratio of 500:1 at 22 °C for 
0, 1, 5, 10, and 30 min, respectively. After quenching, 45 μg samples from each time point were 





















Table2. Fitted parameters for GR A-NTD, GR A-NTDDBD, GR C3-NTD, and GR 
C3-NTDDBD constructs from TMAO induced folding transitions. 
 
Constructs ∆G U→F (kcal/mol) m-value (kcal/(mol*M)) 
A-NTD 10.1±0.5 -8.8±0.8 
A-NTDDBD 5.7±0.4 -4.9±0.3 
C3-NTD 7.6±0.3 -6.7±0.4 

















Chapter 4- Binding Energetics of the Two-domain Constructs of GR 
Translational isoforms to GR Response Element 
4.1 Abstract 
Allostery, by which remote sites of a protein are energetically coupled to elicit a functional 
response, manifests as action at distance. Thus exploring one region’s influence on the coupled 
region’s binding energetics to its ligands will help to understand the coupling mechanism. To gain 
further insight into the allosteric coupling between NTD and DBD, binding affinities to the half 
site of a GRE were measured for the NTDDBD constructs of the eight GR translational isoforms. 
The binding was monitored by the change in the fluorescence anisotropy of the half site GRE 





, corresponding to the binding affinities of C2-NTDDBD and 
D2-NTDDBD, respectively. The length of R domain modulated the DBD’s binding affinity to 
GRE, as seen in the A, B, C1 and C2 isoforms. This suggests that the R domain is coupled to the 
DBD, either directly or indirectly. The D2-NTDDBD had the highest binding affinity, which 
suggests that the D2 region of the NTD contributes significantly to the favorable coupling between 
the F domain and the DBD.  
4.2 Introduction 
One common role of a DBD in transcription factors is to anchor the transcription factor to 
the response element on a chromosome. The DBD of GR tethers it to the glucocorticoid response 
element (GRE) in the promoteR domain of a regulated gene. A typical consensus GRE is a 
palindromic repeat of 5’-AGAACA-3’ half site separated by a three base pair spacer [16]. Each 
half site is a binding site for one GR monomer. Many natural response elements do not completely 
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match the perfect palindromic consensus, and the usage frequency of each nucleotide at each 
position is reported and shown in Fig. 14 [22]. In addition, half-site GRE usually forms a 
composite response element with other transcription factors’ response elements [57]. The 
transcriptional activity of GR is usually weak when bound to a half-site or a full length response 
element, and multiple response elements are often found in close vicinity in the regulatory region 
of GR controlled genes [16]. There is both inter-site cooperativity and intra-site cooperativity 
reported for GR [29]. In this chapter, the binding affinities to the typical half site GRE 
5’-AGAACA-3’ are measured for the two-domain constructs of the eight GR translational 
isoforms. 
4.3 Materials and methods 
Protein expression, purification and storage 
Protein expression, purification and storage have been previously described in Chapter 3. 
6FAM labeled half site GRE and control oligonucleotide 
Oligonucleotides containing half site GRE (5’-6FAM gcgcAGAACAggacgcg-3’ and 5’- 
cgcgtccTGTTCTgcgc-3’) were synthesized by Integrated DNA Technologies (IDT) with HPLC 
grade purification and annealed with each other to get the double stranded 6FAM labeled half site 
GRE. Nonspecific control oligonucleotides (5’-GCGCCATATGATACGCG-3’ and 5’ - 
CGCGTATCATATGGCGC-3’) were synthesized as complimentary strands by IDT and annealed 
to each other to get the double stranded control oligonucleotide. 
Binding affinity measurement monitored by fluorescence anisotropy change 
The binding experiments were carried out in the following buffer: 10mM HEPES (pH7.6), 
80mM NaCl, 1mM EDTA, 5mM MgCl2, 1mM DTT, 200ug/mL BSA and 5uM control 
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oligonucleotide. For each data point, 25 nM 6-FAM labeled half site GRE was incubated with 0 
μM up to 10 μM of GR two-domain construct at 22°C for 30 minutes. Fluorescence anisotropy for 
mixtures at each GR concentration was measured using an Aviv ATF 105 fluorometer equipped 
with polarizers. The GR construct and 6FAM labeled half site GRE mixture (150 µL) was allowed 
to rest in a “sub micro” fluorometer cell at 22°C (Santa Cells) for 2 minutes to allow for 
temperature stabilization and then the mixture was excited at a wavelength of 495nm. Anisotropy 
at 521nm was recorded as a function of GR construct concentration.  
Binding affinity fitted with single site binding model 
Binding affinity was fitted with nonlinear least squares fitting to the raw data with the 















Where Aobs is the observed anisotropy value at each GR concentration, AfreeGRE is the anisotropy 
value of the free GRE oligonucleotide, AboundGRE is the anisotropy value of the GRE 
oligonucleotide in complex with GR, Ka is the binding affinity between the half site GRE and GR. 
The fitting parameters are AfreeGRE, AboundGRE, and Ka. 
4.4 Results and discussion 
Eight GR translational isoforms have variable binding affinities to GRE 
Binding affinities of the GR two-domain constructs to glucocorticoid response element 
(GRE) were measured by monitoring the change in anisotropy of the 6FAM labeled half-site GRE 
as shown in Figure 16. The fitted binding affinity for each isoform is shown as a bar plot in Fig. 
17 and also listed in Table 3 with the other fitting parameters. The binding affinities for the eight 
translational isoforms varied approximately 5 fold. The two-domain constructs of the eight 
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translational isoforms all contain the same intact DBD to bind to the GRE. The variable binding 
affinity to the GRE indicates that the NTD of different translational isoforms allosterically 
modulates DBD binding affinity to GRE. The coupling between NTD and DBD is consistent with 
previous reports that the GRE is an allosteric effector of GR [16, 17, 19, 22]. Detailed examination 
of the binding affinities of the translational isoforms in light of their domain architecture (shown 
in Fig. 18) can suggest testable hypotheses.  
For example, A, B, C1 and C2 isoforms all contain the DBD, the F domain and a variable 
sized R domain, which accounts for differences in binding affinities to GRE. We hypothesize that 
the R domain is allosterically coupled to the DBD, either directly or indirectly through the F 
domain. 
In C3, D1, D2 and D3 isoforms, the R domain is entirely missing and they have variable 
lengths of the F domain. As discussed in chapter 3, the F domain is favorably coupled to DBD. 
The significantly higher binding affinity of D2 isoform suggests that the N terminal domain of D2 
isoform may contribute significantly to the favorable coupling between F domain and DBD. 
4.5 Conclusions 
The NTDDBD constructs of the eight GR translational isoforms had variable binding 
affinities to the GRE. As they all have the same intact DBD, which contains the binding site to 
GRE, these results suggest that the NTD is allosterically coupled to the DBD, and the coupling is 






Figure 14 | Pattern of Glucocorticoid response element (GRE) 
This is a figure modified from reference [22]. Positions 1-6 make up the left half-site, 10-15 make 
up the right half-site, and positions 7-9 makes up a spacer between the two half-sites. The two 
















Figure 15 | Illustration of experimental design for binding GR’s two-domain constructs to 
6FAM labeled GRE. 
In the binding experiment, 6FAM labeled GRE was kept at constant concentration. And 
concentration of the GR construct was gradually increased. In absence of GR, the GRE is in the 
free form and tumbling faster in the solution, so smaller fluorescence anisotropy is observed. In 
the presence of a saturating concentration of GR, the GRE is mostly in the bound complex and 
tumbles slower in solution (larger anisotropy). Monitoring the fluorescence anisotropy change 












Figure 16 | Binding of NTDDBD two-domain constructs of eight GR translational isoforms 
to GRE monitored by fluorescence anisotropy change 
Fluorescence anisotropy change at 521nm of the 6FAM labeled GRE as a function of the 
concentration of GR isoforms. Binding was conducted with 25nM 6-FAM labeled GRE in buffer 
containing 10mM HEPES (pH7.6), 80mM NaCl, 1mM EDTA, 5mM MgCl2, 1mM DTT, 10% 
glycerol, 200ug/mL BSA and 5uM control oligonucleotide. Curves were fitted with the single 

















Figure 17 | Bar plot comparison of eight GR translational isoforms’ binding affinity to half 
site GRE. 
The binding affinity was fitted from the anisotropy data of Fig. 15. Shown in the inset is the 
domain structure of the eight, two-domain constructs used. Error bars indicate the fitting errors. 












Table3. Fitted parameters for binding between NTDDBD two-domain constructs of eight GR 
translational isoforms to 6FAM labeled GRE. 
 
  Ka (M-1) Ab Af 
  Value 
Fitting 
Error 
Value Error Value Error 
A-NTDDBD 1.49E+06 1.50E+05 0.14955 1.51E-03 0.07977 1.16E-03 
B-NTDDBD 1.23E+06 6.22E+04 0.19582 1.35E-03 0.07986 9.02E-04 
C1-NTDDBD 9.64E+05 9.64E+04 0.14501 1.56E-03 0.08026 8.71E-04 
C2-NTDDBD 8.40E+05 5.45E+04 0.15398 1.26E-03 0.08051 6.37E-04 
C3-NTDDBD 1.12E+06 8.37E+04 0.14593 1.18E-03 0.07974 7.33E-04 
D1-NTDDBD 1.06E+06 8.23E+04 0.26802 3.50E-03 0.08179 2.12E-03 
D2-NTDDBD 4.15E+06 3.29E+05 0.15176 8.94E-04 0.07935 1.19E-03 
D3-NTDDBD 2.95E+06 2.23E+05 0.1784 1.43E-03 0.07908 1.38E-03 
Ab: fluorescence anisotropy of the bound complex 










Chapter 5-Cell Based Functional Assay to Measure the 
Transcriptional Activity and Relative Binding Affinity of GR 
5.1 Abstract 
To further test the hypothesis generated from the biophysical studies，a dual luciferase 
reporter assay was developed using U-2 OS cells. Transcriptional activity at different GR 
expression vector dosages was measured for each translational isoform, and the maximum 
transcriptional activity and EC50 were fitted from these dosage curves. The EC50 of the active 
isoforms significantly correlated with the in vitro measured binding affinity from Chapter 4, 
indicating that the in vitro measured binding energetics represent the binding in cells. Different 
transcriptional activities of the eight translational isoforms were observed and did not correlate 
with their binding affinities to GRE. In addition, the luciferase assay was reformatted into a 
competitive transfection assay and shown to be valuable in measuring the in vivo binding strength 
of the inactive isoforms to GRE. 
5.2 Introduction 
The biological role of GR as a transcription factor provides a convenient way to assay its 
function through reporter gene assays. Development of a functional assay enables us to link the 
biophysical characteristics with protein function, and also to test the hypotheses generated from in 
vitro assays. 
The different transcriptional activities of the full-length translational isoforms have been 
reported [25]. As the experimental system in this thesis are NTDDBD constructs of GR, it was 
necessary to assay the activity of these two-domain constructs. Truncation of the LBD removes 
the transcriptional activity dependence on hormone, and generates a constitutively active construct 
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[27]. The transcriptional activity of my eight two-domain constructs was measured using a dual 
luciferase reporter assay. 
A luciferase reporter assay measures the activity of a transcription factor through the 
luminescence of luciferase. In our system, the transcription factor expression vector is 
co-transfected with a Gaussia luciferase vector [58], in which GRE has been cloned in the 
regulatory region. To take into account the differences in cell density and transfection efficiency, 
we also co-transfect a control vector that encodes Cypridina luciferase [59] not under control of 
the investigated transcription factor. Both luciferases are engineered to be mostly secreted to the 
medium and are combined in the dual luciferase assay (as illustrated in Fig. 18). 
To measure the transcriptional activity of transcription factors in a reporter gene assay, it is 
important to ensure that the reporter vector is fully bound by the transcription factor. Otherwise, 
the activity measured at non-saturating concentrations of transcription factor does not represent 
the relative activity of each transcription factor as they may have different binding affinities to the 
response element. To do this, a dosage curve was performed for each translational isoform. 
To enable an approximation of the binding affinity of the inactive constructs (D1, D2, and D3) to 
GRE, a competitive transfection assay is also described in this chapter. 
5.3 Materials and methods 
Mammalian cell expression vectors for the NTDDBD constructs of GR translational isoforms 
Plasmid PJ603-A NTDDBD to express human GR A isoform NTD and DBD two-domain 
construct in U-2 OS cells was optimized for mammalian cell expression, synthesized by DNA 2.0 
(Menlo Park, CA), and inserted into the PJ603 mammalian expression vector under CMV 
promoter control. Plasmids PJ603-B NTDDBD, -C1 NTDDBD, -C2 NTDDBD, -C3 NTDDBD, 
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-D1 NTDDBD, -D2 NTDDBD and -D3 NTDDBD were made by inserting the codons for each 
respective isoform amplified from PJ603 A NTDDBD into the NheI and XhoI sites of the PJ603 
vector. 
Luciferase reporter vectors 
Plasmid GRE2-Gluc, to express secreted Gaussia luciferase under the control of two 
tandem full-length GREs in the promoteR domain, was made by inserting an oligonucleotide 
containing two tandem full-length GREs, 5’-aattcAGAACAggaTGTTCTgagatccgtagc 
AGAACAggaTGTTCTgagatccgtagcg-3’, into the EcoRI and BamHI sites of the pGluc-miniTK 
vector (NEB). Plasmid GRE4half-Gluc, to express secreted Gaussia luciferase under control of 
four tandem half site GREs, was made by inserting an oligonucleotide containing four tandem 
half-site GREs, 5’-aattcAGAACAggagagatcgtagcAGAACAggaagatccgtagcAGAACAggagagatcc 
gtagcAGAACAggaagatccgtagcg-3’, into the EcoRI and BamHI sites of pGluc-miniTK vector. 
Plasmid pCluc-miniTK2 vector (NEB) to express Cypridina Luciferase was utilized as an internal 
control in the co-transfection to account for cell density differences and transfection efficiency 
differences in each well. 
Mammalian cell culture and transfection 
U-2 OS cells (American Type Culture Collection) were maintained in modified McCoy's 5a 
medium (Corning Cellgro) supplemented with 10% fetal bovine serum and 100 U/mL penicillin 
and 100 ug/mL streptomycin. To transfect U-2 OS cells at about 80%-90% confluence, 
X-tremeGENE HP DNA transfection reagent (Roche) was used at 2 μl per 1μg DNA according to 
the manufacturer’s manual.  
Western blots 
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U-2 OS cells were plated on 6 well plates at a density of 5*10
5
 cells/well. After 18 hours, 
50 ng of GR isoform expression vector with 450 ng Salmon Sperm DNA (Invitrogen) as 
transfection boosting reagent was transfected into each well with X-tremeGENE HP DNA 
transfection reagent (Roche) following the manufacturer’s protocol. Twenty-four hours post 
transfection the medium was changed once. After 48 hours, the cells were collected for the assay.  
Cells were scraped from each well with PBS, and pelleted by centrifuging at 1500 rpm for 
10 minutes in a bench top centrifuge. Fifty μL of lysis buffer (8 M urea, 20 mM Tris-HCl, 500 
mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM 
beta-glycerophosphate, 1 mM Na3VO4 and 1 µg/ml leupeptin, pH 7.5) was added into the cell 
pellet from each well. To reduce the viscosity, cells were passed through a 26G3/8 syringe needle 
10 times and then the cell lysate was centrifuged at 14000rpm for 30 minutes. Supernatant was 
collected and the total protein concentration was measured by Bradford assay (Biorad). Five ug of 
total protein was loaded onto each well of a 4–15% Mini-PROTEAN TGX Precast Gel (BioRad), 
and separated in 1x Tris/Glycine/SDS gel running buffer. Transfer of the protein from SDS page 
gel to PVDF film was done in transfer buffer (25 mM Tris-HCl, pH 8.3, 192 mM glycine, 20% 
methanol) under 120V for 15 minutes. After blocking in 5% nonfat milk for 1 hour, the PVDF 
film with protein transferred on it was incubated with 5000 fold diluted primary antibody for GR 
(BD Transduction Laboratories, 611226) or 5000 fold diluted antibody for p150glued (BD 
Transduction Laboratories, 610473), which served as loading control, at 4 ˚C overnight. The next 
morning, after washing with PBST buffer (PBS supplemented with 0.1% Tween 20) three times, 
the PVDF film was incubated in the 10000 fold diluted HRP-linked anti-mouse IgG (GE 
healthcare, NA931). The detection was done with Amersham ECL Prime Western blotting reagent 
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(GE healthcare, RPN2232). 
Immunostaining 
U-2 OS cells were plated on 6 well plates with 15mm round German coverslips. All the 
culture and transfection procedures are the same as done for the cells treated for Western blot 
experiments. After 48 hours, cells were rinsed with PBSM (PBS with 2 mM MgCl2) three times, 
and fixed with 4% paraformaldehyde in PBSM at room temperature for 10 minutes. Afterwards, 
each coverslip was rinsed with PBSM three times again, and quenched with 50 mM NH4Cl in 
PBSM. Then the slide was placed in PBSTB (PBS with 0.1% Triton X-100, 1%BSA) for 30 
minute at room temperature to permeabilize cells and block nonspecific binding. Thereafter, the 
slide was incubated with primary rabbit antibody for GR (cell signaling, #3660) which is 5000 
fold diluted in PBSTB for 1 hour at room temperature. Then the slide was washed three times with 
PBSM and then incubated with the Alexa Fluor® 488 Goat Anti-Rabbit IgG which is 600 fold 
diluted in PBSTB for 30 minutes at room temperature in the dark. Next the slide was incubated in 
PBSM with 0.2 ug/mL DAPI (Invitrogen) and 5 unit/mL Rhodamine Phalloidin (Invitrogen) for 
10 minutes at room temperature in the dark to stain the nuclei and F-actin. After that, each slide 
was washed with PBSM twice and mounted onto a microscope slide with Fluoromount (Sigma), 
and kept in the dark for drying. 
Images were taken with an inverted light microscope (Axiovert 200, JHU Integrated Imaging 
Center). All images were taken the same day using the same gain, exposure times, and filter 
configurations (DAPI, FITC, and Texas Red filters of Sedat3 filter set). 
Luciferase dosage curve to measure transcriptional activity of GR translational isoforms 
U-2 OS cells were plated on 96 well plates at a density of 3*10
4
 cells/well as measured by 
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hemocytometer. After 18~24 hours, when the cells reach about 80-90% confluence, 
X-tremeGENE HP DNA transfection reagent (Roche) mediated chemical transfection was carried 
out. For the transcriptional activity dosage curve, 40 ng GRE2-Gluc, 40 ng pCluc-miniTK2 and up 
to 5 ng GR expression vector were co-transfected into U-2 OS cells on a 96-well plate. After 48 
hours, Gaussia luciferase activity and Cypridina luciferase activity were measured with the 
BioLux® Gaussia Luciferase Assay Kit (NEB) and the BioLux Cypridina Luciferase Assay Kit 
(NEB) respectively on a TriStar² LB 942 Multidetection Microplate Reader (Berthold) according 
to the manufacturer’s protocols. In each experiment, the Gaussia luciferase activity (normalized 
with the Cypridina luciferase activity) was measured in triplicate and averaged. Data were fitted to 
the dose response function as follows. 
 
 
Where Obs is the observed luciferase expression level under each transfection condition. Xbasal is 
the Gaussia luciferase expression level without GR regulation. Xmaximum is the Gaussia luciferase 
expression level when the GRE in its promoter region is fully bound by GR.  CGR is the amount 
of GR construct vector transfected into U-2 OS cells. EC50 is the GR expression vector 
transfection amount when the Gaussia luciferase expression level is half of its maximum. p: Hill 
coefficient. In this equation, p is a practical value introduced in the fitting equation, to transform 
DNA vector amount to protein expression amount, to consider that different isoforms may have 
different binding cooperativities, different degradation rates, different expression levels, and 
different nuclear localization efficiencies. 

















For the competitive transfection assay, 40 ng of GRE4half-Gluc, 40 ng of pCluc-miniTK2, 
3 ng of PJ603 C3-NTDDBD, and up to 16 ng of plasmids coding for the competitors were 
co-transfected into U-2 OS cells on 96-well plates. After 48 hours, the luciferase expression level 




Where Obs is the observed luciferase expression level under each transfection condition. XC3 is the 
expression level of Gaussia luciferase under the control of the two-domain constructs of C3 
isoform. XCompetitor is the expression level of Gaussia luciferase under the control of the competitor. 
CCompetitor is the amount of competitor vector transfected into U-2 OS cells. EC50 is the competitor 
vector transfected when the Gaussia luciferase expression level is half of the sum of XC3 and 
XCompetitor. p is the Hill coefficient. In this equation, p is a practical value introduced in the fitting 
equation, and its purpose is the same as described in the previous paragraph.  
5.4 Results and discussion 
U-2 OS cells transiently transfected with each isoform can express each isoform by itself 
As shown in the Western blot (Fig. 19), U-2 OS cells transiently transfected with the 
NTDDBD construct of the GR translational isoforms can express each isoform with a similar 
expression level. In human cells, the Kozak context for the first start codon of GR is not strong, 
and consequently, multiple translational isoforms are expressed through ribosome leaky and/or 
shunting mechanisms [25]. In this study, the codon was optimized and for each isoform, the initial 

















Different GR translational isoforms have similar nuclear translocation efficiencies 
As shown in the multicolor immunostaining (Fig.20a), the constitutively active constructs 
of the eight translational isoforms reside both in nuclei (as evidenced by the overlap of green and 
blue) and in the cytoplasm (as shown by the overlap of green and red). Nuclear percentage is 
calculated by dividing the intensity of the green dye overlapped with blue dye with the total green 
dye intensity as shown in Fig.20a. Between four and seven cells were used for each isoform for 
quantification. Average values and standard errors are reported in the graph (Fig.20b). It can be 
seen that different translational isoforms have indistinguishable nuclear localization efficiencies. 
Different translational isoforms have different transcriptional activities 
Each GR vector was separately transfected in increasing amounts to measure the 
transcriptional activity of each GR translational isoform. The maximum transcriptional activity 
and EC50 for each isoform were fitted from these dosage curves with the dose response function 
(listed in Table 4). As shown in Fig. 21, the two-domain constructs of the eight translational 
isoforms have different activities, and show similar patterns to those reported for the full-length 
construct under hormone stimulation [25]. A, B, C1, C2 and C3 constructs, whose F domain is 
complete (as shown in Fig. 1), all have significant transcriptional activities. Their activity is highly 
sensitive to the variable length of the R domain. Remarkably, the C3 isoform, where the R domain 
is completely truncated, has more than 3 fold higher activity compared with the other isoforms. 
D1, D2 and D3 isoforms, in which the activation function 1 (AF1) is fully truncated (as illustrated 
in Fig. 2), have very low transcriptional activities. As expected, DBD by itself did not have 
transcriptional activity. 
Correlation between the binding affinity measured in vitro and the EC50 fitted from luciferase 
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dosage curve 
From the luciferase assay dosage curve (Fig. 21), the EC50 can be fitted for the A, B, C1, 
C2 and C3 isoforms (listed in Table 4). Pearson correlation analysis was performed on the EC50 
and the binding affinity (Chapter 4, Table 3) for the five active isoforms. As shown in Fig. 22, 
there is significant correlation between the EC50 and binding affinity. The importance of this 
correlation is two-fold. First, the EC50 fitted from the luciferase dosage curve approximates the 
binding of each GR construct to the GRE cloned into the luciferase vector. Second, it 
demonstrates that the in vitro measured binding affinity provides an accurate representation of the 
in vivo behavior, suggesting that in spite of the fact that the protein expressed in mammalian cells 
can undergo post translational modifications and may have different properties compared to the 
proteins purified from E. coli, these differences do not impact the interpretation of results. 
Competitive transfection assays can approximate the binding affinity of the inactive isoforms 
As the D1, D2 and D3 isoforms have very low activity, it is not possible to accurately fit 
their EC50 from the luciferase assay dosage curve (shown in Fig. 21). To approximate the in vivo 
binding affinity of these inactive isoforms, a competitive transfection strategy was designed using 
the luciferase reporter assay. The amounts of the following components were kept constant in the 
transfection: GRE controlled Gaussia luciferase vector, internal control Cypridina Luciferase 
vector and GR C3 isoform expression vector. The amount of competitor (inactive constructs 
bearing the DBD) was gradually increased to compete with the C3 isoform for binding to the GRE. 
A stronger competitor with higher binding affinity will replace the C3 isoform from GRE with a 
lower dose, thus has a smaller EC50 in the competitive transfection assay. As shown in Fig. 23, 
the competitive transfection assays were performed on D1, D2, D3 and DBD to compete with C3 
 58 
isoforms. The fitted EC50 showed significant correlation with the in vitro measured binding 
affinity, as shown in Fig. 24. This suggests that competitive transfection assay can approximate the 
binding affinity of the inactive isoforms. 
Lack of correlation between the transcriptional activity and binding affinity of eight GR 
translational isoforms 
Thus far, it has been shown that the transcriptional activity (listed in Table 4) and binding 
affinity to GRE (listed in Table 3) can be measured for the two-domain constructs of GR. 
Comparing the binding affinity to GRE and transcriptional activity did not reveal a significant 
correlation as shown in Fig. 25. If one examines the binding affinity and transcriptional activity in 
detail, there seem to be three groups. Remarkably, the C3 isoform has medium binding affinity to 
GRE and yet it has more than 3 fold greater activity compared with other isoforms. The A, B, C1 
and C2 isoforms, which contain the F domain as well as an R domain of different lengths, show 
medium levels of both transcriptional activity and binding affinity. Minimum activity is shown by 
the D1, D2 and D3 isoforms, in which the co-regulators’ binding sites in AF1 is missing. 
Surprisingly, two of the D isoforms, D2 and D3 have much higher binding affinity than the other 
isoforms. Thus they may work as strong competitors to occupy the GR response element (GRE) 
and regulate the apparent total transcriptional activity of GR in cells. From the binding and 
activity data, it is clear that GR can exploit the eight translational isoforms to generate a broad 
spectrum of transcriptional efficiencies.  
The lack of correlation between binding affinity to DNA response element and 
transcriptional activity seems to be a puzzling observation, because binding energetics to the 
response element is generally believe to determine their specificity and activity [28, 29]. In the 
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following chapters, the allosteric coupling mechanism will be investigated in an attempt to resolve 
this puzzling observation.  
5.5 Conclusions 
The constitutively active constructs of the eight GR translational isoforms had varying 
activities as measured in the dual luciferase assay dosage curves. The correlation between the 
EC50 fitted from luciferase assay and the in vitro measured binding affinity for the active isoforms 
confirmed that the in vitro measured binding energetics recapitulate the in vivo binding. In 
addition, the competitive transfection strategy described in this chapter provides access to the 
binding affinity of the inactive isoforms to GRE. The absence of a correlation between the binding 
affinity to GRE and the transcriptional activity of the eight isoforms suggests that allostery may 





























Figure 19 | U-2 OS cells transiently transfected with each isoform can express each single 
isoform shown by Western blot. 
In the upper part of the figure is shown the loading control, p150. In the lower part of the figure is 















Figure 20 | Immunostaining of U-2 OS cells transfected with GR translational isoforms.  
a. Multicolor immunostaining of U-2 OS cells transfected with A, B, C1, C2, C3, D1, D2 and D3 
constructs (labeled in top left of each window). Green: Alexa 488 linked goat anti-mouse IgG 
staining GR. Blue: DAPI staining nuclei. Red: Rhodamine Phalloidin staining F-actin. b. Nuclear 
localization efficiency for the eight GR translational isoforms. Nuclear percentage is calculated by 
dividing the intensity of the green dye overlapped with blue dye with the total green dye intensity 
of the cell as shown in a. Between four and seven cells were used for each isoform to do the 




Figure 21 | Dosage curve of the transcriptional activity of the two-domain constitutively 
active constructs of the eight translational isoforms monitored by dual luciferase reporter 
assay.  
Curves fit the data points with the dose response function, . Amax 
represents the maximum transcriptional activity, and EC50 represents the GR construct amount 
transfected when the transcriptional activity is half of the maximum. C is the amount of GR 
construct transfected at each data point. A practical value, p, was introduced in the fitting equation 
for the following reasons: to transform DNA vector amount to protein expression amount, to 
account for the probability that different isoforms may have different degradation rates, different 
























Figure 22 | Correlation between EC50 fitted from in vivo dosage curve and in vitro measured 
binding affinity for five active GR translational isoforms. 
Correlation between the EC50 fitted from the in vivo dosage curve as listed in Table 4 and the in 
vitro binding affinity as shown in table 3, suggesting that the in vitro binding affinity represents 













Figure 23 | Competitive binding luciferase assay comparing increasing amounts of D1, D2, 
D3 and DBD co-transfected with the C3 isoform  
The transcriptional activity of C3 isoform in absence of competitors was normalized to 1.Curves 
fit the data points with the dose response function, . Acompetitor 
represents the transcriptional activity when only 16 ng of competitor is transfected. EC50 
represents the competitor construct transfected when the transcriptional activity is half of the C3 
maximum. C is the amount of competitor construct transfected at each data point. The value p is a 
















Figure 24 | Correlation between the EC50 fitted from the competitive binding assay and the 
in vitro measured binding affinity for D1, D2 and D3 isoforms.  
The correlation demonstrates that the competitive luciferase assay can provide qualitative 











Figure 25 | Lack of correlation between transcriptional activity and binding affinity to GRE 
of the eight GR translational isoforms. 
The transfection activity is fitted from the luciferase assay dosage curve as listed in Table 4, and 
the binding affinity is measured by monitoring the anisotropy change of the 6FAM labeled GRE as 











Table 4. Fitted parameters from the luciferase assay dosage curve for A, B, C1, C2 and C3 
five active isoforms. 
 
Construct 
Transcriptional activity p EC50 (ng) 
Value Error Value Error Value error 
A 27.64 0.62 1.44 0.05 0.58 0.01 
B 35.26 0.79 1.15 0.03 0.62 0.02 
C1 31.38 1.70 1.32 0.06 1.25 0.06 
C2 23.98 1.87 1.27 0.08 1.57 0.11 















Chapter 6-Bidirectional Competing Allosteric Coupling in GR 
6.1 Abstract 
Previous chapters have demonstrated the unfavorable coupling between the regulatory (R ) 
and functional (F) domains within the NTD, and favorable coupling between the F domain and 
DBD. Examination of the transcriptional activity and binding affinity data in detail suggests that 
there is favorable coupling between the R domain and the DBD. To test this hypothesis, R 
domains of different translational isoforms were directly linked to the DBD through an eleven 
amino acid flexible linker. The binding affinities of the conjoined constructs were then compared 
with the linker DBD control construct using the competitive transfection assay. Linking the R 
domains of the A and B isoforms to DBD significantly increased DBD’s binding affinity to GRE, 
supporting the hypothesis that the R domain is favorably coupled to DBD. As the F and R domains 
in the NTD are unfavorably coupled to each other, and both are favorably coupled to the DBD, 
there appears to be a competing allosteric coupling in the constitutively active GR two-domain 
construct. DBD is favorably coupled to the F domain directly, and unfavorably coupled to the F 
domain indirectly through its interactions with the R domain. In different translational isoforms, 
modulating the length of the R domain also regulates the indirect component of the coupling 
energetics. 
6.2 Introduction 
In chapter 2, a thermodynamic characterization revealed that the NTD of GR is composed 
of two functionally distinct regions, a regulatory (R) and a functional (F) domain, which are 
negatively coupled to each other. In chapter 3, by comparing the TMAO induced folding of C3 
NTD (F domain) and C3 NTDDBD (F –DBD), we found that the F domain is positively coupled 
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to the DBD. We note that these two couplings alone cannot explain why the A isoform (which is 
composed of R, F and DBD) has higher binding affinity to GRE than the C3 isoform (which is 
composed of F and DBD). These observations are possible however, if the R domain and DBD are 
also positively coupled to each other. To test this hypothesis, R domains of the A (GR 1-97), B 
(GR 27-97), C1 (GR 86-97) and C2 (GR 90-97) isoforms were directly linked to DBD through an 
eleven amino acid, flexible linker (GTGGSGGSGGS). The binding affinities of these constructs to 
GRE were compared with DBD through the competitive transfection assay, revealing that the R 
domain and DBD are indeed favorably coupled. The implications of these results are discussed. 
6.3 Materials and methods 
Constructs 
Amino acids 1-97 of GR were linked to DBD with an eleven amino acid, flexible linker 
(GTGGSGGSGGS, plasmid PJ603-1-97-11aa-DBD). This plasmid was made by a PCR that 
deleted the codons for GR 98-420 from PJ603-A NTDDBD and had BamHI and KpnI sticky ends 
for ligation of an oligonucleotide coding for GTGGSGGSGGS. Plasmid PJ603-27-97-11aa-DBD, 
-86-97-11aa-DBD, -90-97-11aa-DBD and -11aa-DBD were made by amplifying the appropriate 
the codons from PJ603-1-97-11aa-DBD and inserting them into the NheI and XhoI site of PJ603 
vector. All the single point mutations on GR constructs were made by site directed mutagenesis 
[60]. 
Competitive transfection assay 
The same as described in Chapter 5.  
6.4 Results and discussion 
Directly linking R domains of A and B isoforms to DBD significantly increases DBD’s binding 
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affinity to GRE 
As shown in Fig.26, linking the R domain of the A or B isoform (RA or RB, respectively) to 
DBD significantly increases the binding affinity of DBD to GRE. The RA-linker-DBD construct 
and RB-linker-DBD constructs have significantly lower EC50 values compared to the linker-DBD 
construct in the competitive transfection assay. In contrast, linking the R domain of the C1 or C2 
isoform to DBD doesn’t significantly change the binding affinity of DBD to GRE, as the 
RC1-linker-DBD and RC2-linker-DBD constructs show similar EC50s to the linker-DBD construct. 
In summary, the segment 1-85, which is unique to A and B isoforms, is involved in the favorable 
coupling network between R and DBD. Therefore, changing the length of the R domain in the 
transcriptionally active isoforms regulates the coupling energetics between the R domain and 
DBD. 
Bidirectional energetic couplings are competitive in constitutively-active, two-domain GR 
constructs 
As summarized in Fig.27, there are two allosteric coupling mechanisms that compete with 
one another in the two-domain construct of GR. DBD is favorably coupled to the F domain in the 
NTD through a direct manner, and unfavorably coupled to the F domain via an indirect 
mechanism that is mediated through interaction with the domain. If the coupling is illustrated in 
the pie chart shown in Fig.28, we can see that binding of GRE to DBD stabilizes DBD, and via the 
direct, favorable coupling it will stabilize F domain and favor co-regulator binding to turn on gene 
transcription. Concomitantly, through an indirect mechanism, stabilization of DBD will stabilize 
the R domain. However, because of the negative coupling between R and F domains, stabilization 
of the R domain will consequently destabilize the F domain and disfavor co-regulator binding. In 
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other words, binding DNA to the same site elicits two different, opposite effect. 
6.5 Conclusions 
It has been shown that allostery between the R domain and DBD can be probed using a 
functional assay. Linking the R domains of A and B isoforms to DBD significantly increased 
DBD’s binding affinity to GRE, suggesting that the 1-85 segment of GR, which is unique to GR A 
and B isoforms, mediates the favorable coupling between R and DBD. Combining this with the 
coupling data between R and F domains, and between F domain and DBD reveals a complex 
coupling scheme whereby DNA acting as an allosteric ligand influences transcriptional activity via 
two competing and opposing effects, which are apparently modulated through the expression of 















Figure 26 | Competitive transfection assay comparing a construct with the R domain 
conjoined to the DBD versus the DBD construct. 
a. Constructs used to probe the R domain and DBD coupling. R domain of A, B, C1 and C2 
isoforms were directly linked to DBD through an eleven amino acid, flexible linker 
(GGSGGSGGSGT). b. Competitive transfection assay curves for the R domain (RA, RB, RC1, and 
RC2) joined to DBD constructs versus the DBD construct. c. Fitted EC50 values for each construct 
from the competitive curves shown in b. As shown linking R domain of the A isoform (GR 1-97) 
or the B isoform (GR 27-97) to the DBD through a flexible linker (GGSGGSGGSGT) 
significantly increases the binding affinity of DBD to GRE as shown by the significantly reduced 
EC50 value. Linking the R domain of the C1 isoform (GR 86-97) or the C2 isoform (GR 90-97) to 
DBD doesn’t significantly influence the binding affinity to GRE. This suggests that the R domain 












Figure 27 | Summary of the allosteric coupling network in the two-domain construct of GR. 
Cartoon summary of the thermodynamic coupling scheme in GR two-domain construct, R- and 
F-domains within the intrinsically disordered NTD are unfavorably coupled to each other, and 














Figure 28 | Bi-directional competing allosteric coupling network when allosteric effector 
GRE binds to the DNA binding domain 
When GRE binds to the DBD, it will stabilize DBD and directly stabilize the F domain. 

















Chapter 7-Simulation with Ensemble Allosteric Model for GR 
Translational Isoforms 
7.1 Abstract 
In this chapter, an Ensemble Allosteric Model (EAM) is constructed for each GR 
translational isoform. The biophysical characterization and functional assays provide realistic 
starting values for each thermodynamic parameter in the model. Based on these inputs, we carried 
out an exhaustive search of parameter space to satisfy the experimental constraints on activity and 
binding affinity of the eight isoforms. It was found that with the best fit value of each parameter 
from the EAM, both simulated binding affinity and transcriptional activity, showed significant 
correlation with the experimental data. As such, the EAM can be used to gain insight into the 
observation that binding affinity and transcriptional activity are not correlated for GR translational 
isoforms. 
7.2 Introduction 
Previous chapters discussed the biophysical characterization and cell based functional 
assays that illuminated the allosteric coupling mechanism of GR, as summarized in Fig.27. DBD 
is favorably coupled to the F domain in the NTD through a direct mechanism, and unfavorably 
coupled to the F domain via an indirect mechanism that utilizes the R domain. Binding of GRE to 
DBD stabilizes the DBD, and this will directly stabilize the F domain and favor the binding of 
co-regulators to turn on gene transcription. Concomitantly, through an indirect manner, 
stabilization of the DBD will stabilize the R domain, and stabilization of the R domain will 
destabilize the F domain and disfavor the binding of co-regulators. 
The allosteric coupling mechanism discussed above enables us to build an Ensemble 
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Allosteric Model (EAM) [6, 7] for each translational isoform. A parameter space search was 
carried out using an experimentally guided range for each parameter. 
7.3 Methods 
EAM for each two-domain construct of GR translational isoforms 
The ensemble allosteric model was built for each two-domain construct of GR. The A, B, 
C1 and C2 isoforms each contain three domains, consisting of the F domain, the DBD and a 
variable sized R domain. The C3, D1, D2 and D3 isoforms, on the other hand, contain two 
domains, which include the DBD and variable sized F domains. In each ensemble, the F domain 
and R domain can either be in the folded or unfolded conformation, while the DBD can adopt a 
high affinity or a low affinity state for GRE. With the fully folded state as the reference state, the 
free energy of the other states can be expressed as the free energy to unfold each region, as well as 
the free energy to break the interaction between the other folded domains. For instance, the models 
constructed for the full length A isoform (composed of R domain, F domain and DBD) and the 
most active C3 isoform (composed of the F domain and DBD) are shown in Fig.29.  Based on 


















Consequently, the probability of each state, Pi, can be calculated by dividing each state’s statistical 








In the EAM, the probability of states with the F domain folded and DBD in the high affinity 
conformation represents the relative transcriptional activity for each isoform. The probability of 
states with DBD in the high affinity conformation represents the relative binding affinity for each 
isoform. The temperature used in the simulation is 37˚C. 
Parameter space search with EAM to satisfy experimental constraints 
The biophysical measurements and the allosteric coupling mechanism interpreted from 
experimental results suggested a practical range for each thermodynamic parameter in the model, 
as shown in Table 5. With a step size of 0.5 kcal/mol, combinations of the free energy terms were 
exhaustively explored and the probabilities for the functional states and the probabilities for the 
binding competent states in each isoform’s ensemble were determined for each parameter 
combination. If the calculated results satisfied the constraints based on experimental observations 
(as shown in Table 6), the corresponding parameter set was defined as a positive hit and the 
parameters voted. For detailed derivation please see appendix 2. 
7.4 Results and discussion 
The competing energetic coupling is crucial to satisfy all experimental constraints  
The box chart of the stability of each region is shown in Fig. 30. Also shown are the 
following: the positive coupling energy between the F domain and DBD, the negative coupling 
energy between the R and F domain, and the positive coupling energy between R domain and 
DBD from simulation. This indicates that the coupling energetics are crucial to satisfy all the 
experimental binding affinity and transcriptional activity constraints. In addition, it further 
supports the validity of the coupling model we proposed from the experimental results. 
EAM can capture the absence of a correlation between the transcriptional activity and binding 
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affinity for GR translational isoforms  
With the best fit value of each parameter from simulation (as shown in Fig.30), the 
simulated transcriptional activity and binding affinity and can be calculated for each isoform with 
the full length A isoform as a reference. As shown in Fig.31, both the simulated transcriptional 
activity and binding affinity have significant correlation with experimentally measured values. 
Thus the absence of a correlation between the binding affinity and transcriptional activity of the 
GR translational isoforms can be understood with EAM. 
7.5 Conclusions 
In this chapter, EAM was built for each two-domain construct of GR. A parameter space 
search was carried out to determine the allowable range for the free energy of the R domain, F 
domain, the DBD, and the interaction energy between them to satisfy the experimental constraints. 
Examining the range of values that satisfy each interaction energy term reveals that the coupling 
scheme embedded in the EAM successfully capture the experimental constraints and faithfully 
reproduce both the transcriptional activity and binding affinity data. The ability of the EAM to 
capture the bi-directional cooperativity suggests that the model can be used to explore in detail the 























 -2 2 
∆G(RA) -2.5 2.5 
∆G(RB) -2.5 2.5 
∆G(RC1) -2.5 2.5 
∆G(RC2) -2.5 2.5 
∆G(F) -7 -7 
∆g
int 
(F,DBD) 5 7 
∆g
int 
(RA,DBD) 0 2 
∆g
int 
(RB,DBD) 0 2 
∆g
int 
(RC1,DBD) 0 0 
∆g
int 
(RC2,DBD) 0 0 
∆g
int 
(RA,F) -3 0 
∆g
int 
(RB,F) -3 0 
∆g
int 
(RC1,F) -3 0 
∆g
int 





Table 6. Experimental constraints for relative activity and binding affinity for each isoform 


























Figure 30 | Box chart of satisfied parameter range given experimental constraints on the 
Ensemble Allosteric Model. 
Notice that the competing coupling energetics are crucial to satisfy all experimental constraints. In 
each box, the maximum, the 75 percentile, the median, the 25 percentile, and the minimum are 
show as lines. The average values are shown as squares. The red dashed lines denote the input 












Figure 31 | Correlation between the simulated relative transcriptional activity and binding 
affinity with experimentally measured values. 
Simulated values for transcriptional activity and binding affinity of each isoform are based on the 
ensemble averaged contribution of all the states in the ensemble. The correlation coefficient 








Chapter 8- Applications of EAM: Predictions of Mutational Effects  
8.1 Abstract 
In this chapter, the ability of the EAM to predict mutational effects is explored. From a 
thermodynamic perspective, introducing a mutation to a domain allosterically coupled with other 
domains may either, (1) change the stability of the domain, or (2) weaken the coupling energetics 
between domains. In both of these two scenarios, influences on transcriptional activity and 
binding affinity can be predicted from the EAM. These predictions make it possible and 
straightforward to interpret the mutagenesis effect when pinpointing the molecular basis of 
allosteric coupling. 
8.2 Introduction 
Identifying the residues involved in the allosteric coupling network is important for 
allosteric drug design, as well as obtaining a fundamental understanding of allostery. 
Computationally, the molecular basis of coupling is sometimes predicted by statistical coupling 
analysis using a large set of sequence alignments[61]. This is hardly applicable to ID regions as 
there is usually low sequence conservation of the ID regions within a protein family [62]. 
Experimentally, the molecular basis of allostery is usually studied by examining the effects of 
point mutations on thermodynamic binding or function [63]. In a complicated allosteric protein 
with multiple, coupled domains it is nontrivial to interpret mutagenesis results. However, expected 
mutational scenarios can be predicted from the EAM of various GR isoforms, which makes 
pinpointing the molecular basis of allosteric coupling through mutagenesis possible and 
straightforward.  
Introducing a mutation at one region of a protein may cause different effects: a protein 
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solubility change, a cofactor binding affinity change, a protein thermodynamic stability change, as 
well as a change in the coupling energetics between regions. Among these, protein solubility 
changes can be gauged by Western blot, and the likelihood of a change in binding affinity for a 
binding partner can be largely minimized by avoiding mutations in the annotated binding sites. 
Our EAM model can predict the effects of mutations perturbing inter-domain allostery or altering 
thermodynamic stability. These predictions provide us with anticipated results when screening for 
the molecular basis of the coupling between the R domain and F domain, F domain and DBD, as 
well as the R domain and DBD, as discussed in the future chapters. 
8.3 Methods 
Perturbation of GR EAM with mutagenesis introduced to R domain, F domain or DBD 
In the EAM, the probability of the states with both F domain in the folded conformation 
and DBD in the high affinity state represents the transcriptional activity. The probability of the 
states with the DBD in the high affinity state represents the binding affinity. Thus, both activity 
and binding affinity are functions of the thermodynamic parameters in the system, which can be 











To simulate the scenario that a mutation influences the stability of a target region, a ΔΔG term is 
introduced to the respective region’s stability term. To simulate the scenario that a mutation 
influences the allosteric coupling network between two regions, a ΔΔgint term is introduced to the 
interaction energy term of the two coupled regions. With a mutation introduced to the R domain as 
an example, its thermodynamic effect may be one of the three cases: (I) changing R domain 
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stability; (II) influencing the R domain and DBD coupling; (III) influencing R domain and F 
domain coupling. In case I, the influence on transcriptional activity with wild type (WT) activity 








The influence on binding affinity to GRE with wild type (WT) binding affinity as reference can be 












































8.4 Results and discussion 
Perturbations of GR EAM with mutagenesis introduced to R domain of different translational 
isoforms 
A, B, C1 and C2 isoforms have R domains of different lengths. As shown in Fig. 32a, if a 
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mutation influences the R domain stability, it will significantly influence the transcriptional 
activity of all four isoforms, but not have a significant effect on binding affinity (shown in Fig. 
32b). If, on the other hand, a mutation influences R domain and DBD coupling, it will influence 
the transcriptional activity and binding affinity on A and B isoforms only modestly (shown in Fig. 
32c&d). If a mutation on C2 influences R and F domain coupling, it will influence the 
transcriptional activity significantly while affecting the binding affinity modestly (shown in Fig. 
32e & f). The same mutation on the other hand will not have a large influence on the activity or 
the binding affinity of A, B or C1 isoforms (shown in Fig. 32 e & f). 
As these mutational scenarios suggest a quantitative model of allostery for the different 
isoforms, it provides a tool from which the residues critical for coupling can be identified based on 
their mutational effect. 
Perturbations of GR EAM with mutagenesis introduced to F domain of different translational 
isoforms 
All five active isoforms A, B, C1, C2 and C3 have the same F domain. However, in the 
context of different R domains in each isoform they each respond differentially to perturbations 
within the F domain. As shown in Fig33.a&b, a mutation destabilizing the F domain will decrease 
transcriptional activity of all five isoforms, and will moderately decrease the binding affinity to 
GRE. Likewise, a mutation within the F domain that weakens F domain and DBD coupling will 
also decrease transcriptional activity of all five isoforms, and modestly decrease binding affinity 
(shown in Fig. 33c&d). In addition, mutations within the F domain influencing R and F domain 
coupling have a much more pronounced effect on the transcriptional activity of C2 isoform than 
on the activity of the other isoforms (shown in Fig. 33e&f). This indicates that by measuring 
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transcriptional activity change in the A, B, C1 and C2 isoforms upon mutagenesis within the F 
domain will provide a means of resolving which residues are involved in mediating coupling 
between F and R domains. 
Mutagenesis within the F domain on different isoforms will not distinguish between the 
different scenarios influencing F domain stability and perturbing F domain and DBD coupling. 
The two scenarios have similar effects on both transcriptional activity and binding affinity to GRE. 
Thus to pinpoint the residues within F domain that are allosterically coupled to the DBD, it is 
necessary to employ a control construct. For example, a control in which the F domain is tethered 
to the DBD of another transcription factor provides a gauge of the effect of the mutation on F 
domain stability. 
Perturbations of GR EAM with mutagenesis introduced to DBD of different translational 
isoforms 
All the five active isoforms, A, B, C1, C2 and C3, have the same DBD. As predicted from 
EAM, mutations influencing DBD stability (the free energy difference between the high affinity 
and low affinity state to DNA) will have little influence on the transcriptional activity (shown in 
Fig. 34a); however, it will strongly influence the binding affinity to GRE (shown in Fig. 34b). In 
contrast, mutations weakening F and DBD coupling will strongly influence the transcriptional 
activity (shown in Fig. 34c), and moderately regulate the binding affinity to DNA (shown in Fig. 
34d). Mutations within the DBD may also influence the R domain and DBD allosteric coupling. In 
this case, the mutations will only moderately influence both transcriptional activity and binding 
affinity of A and B isoforms (shown in Fig. 34e&f).  As such, it is possible to distinguish these 
three scenarios by measuring both transcriptional activity and binding affinity changes upon 
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mutation. 
Thus, measuring the DBD’s mutational effect on both transcriptional activity and binding 
affinity on the C3 isoform, which is only composed of F domain and DBD, will help to pinpoint 
the residues involved in the F domain and DBD coupling network. 
8.5 Conclusions 
In this chapter, thermodynamic perturbation of GR EAM was carried out and the effects on 
transcriptional activity and binding affinity were simulated. These predictions are useful for 
distinguishing different scenarios when a mutation is introduced to a system, which makes 
















Figure 32 | Predicted influence on transcriptional activity and binding affinity to GRE when 
mutations are introduced to R domain in different isoforms.  
Three possible thermodynamic scenarios may happen when a mutation is introduced into the R 
domain: influencing R domain stability (shown in a, b), influencing R domain and DBD coupling 









Figure 33 | Predicted influence on transcriptional activity and binding affinity to GRE when 
mutations are introduced to F domain in different isoforms.  
Three possible thermodynamic scenarios may happen when a mutation is introduced into the F 
domain: influencing F stability (shown in a, b), influencing F domain and DBD coupling (shown 












Figure 34 | Predicted influence on transcriptional activity and binding affinity to GRE when 
mutations are introduced to DBD in different isoforms.  
Three possible thermodynamic scenarios may happen when a mutation is introduced into the DBD: 
influencing DBD stability (shown in a, b), influencing F domain and DBD coupling (shown in c, 











Chapter 9-Molecular Basis for the Unfavorable Coupling between 
the Regulatory (R) and Functional (F) Domains in GR NTD 
9.1 Abstract 
In Chapter 2, thermodynamic characterization of GR NTD suggested that the long NTD is 
composed of two functionally distinct regions, the regulatory (R) and functional (F) domains, 
which are negatively coupled to each other. To unravel the molecular basis for the allostery 
between the R and F domains, mutations were introduced into the R domain of different GR 
translational isoforms and the functional effects were measured by the dual luciferase reporter 
assay. Single point mutations within segment 90-97, which corresponds to the R domain of the C2 
isoform, significantly increase the transcriptional activity of the C2 isoform. This suggested that 
the segment 90-97 may be involved in the coupling network between the R and F domains. 
Guided by EAM predictions, the mutational effects of E92Q and E94Q were also tested on A, B 
and C1 isoforms, which further supported the hypothesis that E92 and E94 are involved in the 
coupling between the R and F domains. Several mutations in a predicted coiled-coil (119-132) in 
the F domain showed different effects on the transcriptional activity of the A and C2 compared 
with the C3 isoform. Remarkably, K120Q and S125A mutations significantly increased 
transcriptional activity on A and C2 isoforms, however, they did not significantly influence the 
activity of the C3 isoform, indicating their involvement in mediating the coupling between the F 
and R domains. 
9.2 Introduction 
To investigate the allosteric coupling mechanism, in addition to studying the 
thermodynamics of the coupling, it is also desirable to elucidate the molecular basis of the 
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coupling. Such information can pave a potential way for the design of allosteric drugs, which may 
have advantages over orthosteric drugs [63-65]. Previous literature has usually used point 
mutations and the functional and thermodynamic effects of these mutations were interpreted in the 
framework of a coupling model [63]. As our experimental system is a transcription factor and the 
dual luciferase reporter assay has already been developed as our functional assay, in this chapter, 
we tried to probe the molecular basis of allostery between the R and F domains through this 
functional assay. Mutational effects are interpreted in the context of the GR EAM, which makes it 
straightforward and possible to understand the results. 
9.3 Materials and methods 
Site directed mutagenesis 
All site directed mutagenesis work was done with polymerase chain reactions (PCR) with 
Phusion polymerase (NEB). Complimentary primers were designed to have 10 ~15 nucleotides on 
each side of the manipulation site, and the calculated Tm value of the primer pair should be within 
the range of 70 ˚C to 80˚C for the PCR to be effective. All the primers were synthesized by IDT. 
The PCR was carried out according to the manufacturer’s protocol, and including 1.5% DMSO in 
the reaction is usually helpful. After PCR, 1uL of DpnI (NEB) was added to each 10uL reaction 
product followed by a 4 hour 37˚C incubation to digest the template. After DpnI treatment, the 
PCR product was transformed to chemically competent, NEB5α cells (made in lab, transformation 
efficiency higher than 10
6
). Transformed cells were plated on LB agar plates with selective 
antibiotics and the next morning single colonies were picked up. Plasmids were prepared with a 
mini prep kit and sequenced to check the correctness.  
Western blot 
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Western blot protocol is the same as in Chapter 5.  
Transcriptional activity measurement at the saturated GR vector level 
U-2 OS cells were plated on 96 well plates at a density of 3*10
4
 cells/well. After 18~24 
hours, when the cells reach about 80-90% confluence, X-tremeGENE HP DNA transfection 
reagent (Roche) mediated chemical transfection was carried out. For the transcriptional activity at 
saturated GR vector levels, 40ng GRE2-Gluc, 40ng pCluc-miniTK2 and 5ng GR expression 
vector were co-transfected into U-2 OS cells on a 96-well plate. After 48 hours, Gaussia 
Luciferase activity and Cypridina Luciferase activity were measured as described in Chapter 5. 
9.4 Results and discussion 
Mutations within segment 90-97 dramatically increase transcriptional activity on C2 isoform 
As shown in Fig.1, the C2 isoform (GR 90-525) and C3 isoform (GR 98-525) differ by 
only eight amino acids, MGETETKV, on the C terminal end of the R domain. However, the 
transcriptional activity of the C2 isoform is more than 5 fold lower than that of the C3 isoform 
(shown in Fig. 21). As the R and F domains are negatively coupled to each other (discussed in 
Chapter 6), we hypothesize that this segment, GR 90-97 (MGETETKV) may play an important 
role in regulating the negative coupling between the R and F domains. Inspection of the GR 90-97 
sequence, we note it is highly polar and charged. Single point mutations, E92Q, E92A, T93V, 
E94Q, E94A, T95V and K96Q, were introduced to the C2 construct. All mutants, except the 
K96Q, had similar expression levels compared to wild type C2 as shown by the Western blot 
analysis (Fig.35 upper panel). For all the mutants showed comparable expression levels to the WT 
GR, transcriptional activities were measured (shown in Fig.35 lower panel). Importantly, all 
mutants significantly increased the transcriptional activity compared to wild type C2. 
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Introduction of a mutation to the R domain can produce different effects. They can change 
the R domain stability, influencing the coupling between R and F domains, and/or affecting the 
coupling between the R domain and DBD. As discussed in chapter 8, the EAM of GR could be 
used to make predictions about transcriptional activity and binding affinity changes from each of 
these scenarios. As discussed in chapter 8, and also shown in the left panel of Fig.36, mutations 
within the R domain are predicted to have distinguishable effects on different isoforms under each 
scenario. 
In order to distinguish the different scenarios, two of the mutations, E92Q and E94Q, which 
showed dramatic transcriptional activity increases on the C2 isoform, were also made in the 
context of the A, B and C1 isoforms. Comparing the transcriptional activity to their wild type, 
E92Q and E94Q only caused a significant transcriptional activity increase on the C2 isoform (as 
shown in Fig.36 right panel). This fits the scenario that these two mutations weaken the coupling 
between the R domain and F domain (as shown in Fig.36 left). Thus, E92 and E94 within the R 
domain are involved in the R domain and F domain coupling network. 
Another possibility is that GR 90-97, may contain the co-repressor binding sites, and 
mutations may influence co-repressor binding and increase the transcriptional activity compared 
to wild type C2. To check this possibility, constructs with varied lengths (4aa, 8aa, and 16aa) of 
flexible linkers preceding the N terminus of the C3 isoform were made and transcriptional 
activities were tested. As shown in Fig.37, all these constructs showed significantly decreased 
transcriptional activity compared to the C3 isoform (about 2.5 fold on average), even though they 
had higher activity than the C2 isoform (about 2 fold increase on average). This suggests that the 
N terminus of the C3 isoform may have important functional sites, and coupled folding and 
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binding occurs when it binds to co-regulators. Any additional sequence preceding its N terminus 
may unfavorably influence its ability to adopt the correct conformation upon folding. However, 
the naturally existing C2 isoform, with its unique eight amino acids flanking C3, has even lower 
activity compared to the constructs with flexible linkers on C3. This indicates that there may be 
some specific interaction between these eight amino acids and the F domain.  
Of course these results cannot preclude the possibility that the eight amino acids, 
MGETETKV, contain co-repressor binding sites. The fact that no ligand or cofactor has yet to be 
identified as binding to this region, and the EAM presented here precisely describes the impact of 
mutated residues involved in the coupling, suggest the model is at least plausible, if not probable. 
Mutations on the F domain have different functional effects on A and C2 isoforms compared 
with C3 isoform 
To explore the molecular basis of allostery between the R and F domains in more detail, we 
sought to determine which residues in the F domain are involved in coupling to the R domain. As 
the F domain is greater than 300 amino acids in length, it is not possible to exhaustively explore 
mutational space in this domain. Fortunately, in the F domain, secondary structure predictions can 
pinpoint local element that may form structure. One such region (GR 119-132) is predicted to be a 
coiled-coil. Coiled-coil is a structure motif where 2 to 7 helices interact with each other through 
hydrophobic and electrostatic interactions to form a coil [66]. As discussed above, the influence of 
flexible linkers on the C3 isoform suggests that there may be some important functional regions 
near the N terminus of the F domain, and these regions may be also coupled to the eight amino 
acids unique to the C2 isoform.  As coiled coil regions are often used for interdomain or 
intermolecular interaction, they represent for the residues that may mediate coupling. 
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Selected single point mutations (L119A, K120Q, L122A, S125A and L129A), which were 
predicted to reside on the surface of the coiled coil, were carried out on the C2 and A isoforms to 
check whether any are involved in coupling to the R domain. All mutations were also carried out 
on the C3 isoform to gauge the influence on the stability of the F domain. As predicted by the 
EAM (left panel of Fig.38), if a mutation only destabilizes the F domain or weakens the coupling 
between the F domain and DBD, it would cause transcriptional activity to decrease for all three 
isoforms, with substantially greater decreases for the A and C2 isoforms compared to the C3 
isoform. If a mutation were to weaken the coupling between the R and F domains, it will cause a 
large transcriptional activity increase for the C2 isoform, less of a transcriptional activity increase 
for the A isoform, and no transcriptional activity change for the C3 isoform. 
Among the panel of mutations (Fig.38 right panel), L119A, L122A and L129A are 
predicted to significantly destabilize the coiled-coil region, resulting a transcriptional activity 
decrease for all the isoforms, with the decrease being minimal for the C2 isoform. K120Q and 
S125A mutations are predicted to slightly increase the coiled-coil propensity, and consistently, 
these mutations did not significantly change the transcriptional activity on the C3 isoform. 
However, on the C2 isoform, these two mutations caused a significant transcriptional activity 
increase. The results on all these five mutations are inconsistent with the scenario that these 
mutations only influence the F domain stability or F domain and DBD coupling. Instead, these 
results suggest that the predicted coiled coil region on the N terminal end of the F domain may be 
involved in the allosteric coupling between the R and F domains, with residues K120 and S125 
within this region contribute significantly to the observed negative coupling. 
9.5 Conclusions 
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By testing selected mutational effects on different GR translational isoforms, and 
comparing the results to predictions of the EAM for GR, we were able to probe the molecular 
basis for the negative coupling between the R domain and F domain in the NTD. Our results 
suggest that some residues within segment 90-97, are involved in the coupling between the R and 
F domains. Similarly, some residues (in particular K120 and S125) located within the predicted 
coiled-coil (segment 119-132) in the F domain contribute significantly to coupling the F domain to 



















Figure 35 | Most point mutations within segment 90-97 significantly increase the 
transcriptional activity compared to wild type C2. 
The upper panel is a Western blot testing the expression level of all the mutants made within 
segment 90-97. For the mutants with reasonable expression levels, transcriptional activity was 





Figure 36 | Mutations within R domain on A, B, C1 and C2 isoforms to identify residues 
involved in the R and F coupling network. 
The effect on transcriptional activity when mutations are introduced to the R domain on A, B, C1, 
C2 and C3 isoforms can be predicted based the EAM model for three scenarios (I: influencing R 
domain stability; II: decreasing R and DBD coupling; III: decreasing R and F coupling) as shown 
in the left panel. The bar graph shows the influence of E92Q and E94Q mutations on the activity 
of A, B, C1, and C2 isoforms measured by a luciferase reporter assay. The transcriptional activity 











   
 
Figure37 | Flexible linkers with varied length flanking the N termini of C3 significantly 
decrease the transcriptional activity. 
The upper panel is a Western blot testing the expression level of some constructs with flexible 
linkers preceding the N terminus of C3. For the constructs with a reasonable expression level, 





Figure 38 | Mutations within F domain on A, C2 and C3 isoforms to identify residues 
involved in the R and F coupling network. 
The effect on transcriptional activity when mutations are introduced to the F domain on A, C2 and 
C3 isoform can be predicted based on the EAM model for three scenarios (influencing F domain 
stability, weakening F and DBD coupling or weakening R and F coupling) as shown in the left 
panel. Single point mutants (L119A, K120Q, L122A, S125A and L129A) in the functional domain 
where a coiled-coil structure is predicted, either show indistinguishable activity compared with 
wild type (K120Q and S125A) or significantly lower activity for the C3 isoform (L119A, L122A 
and L129A). It is consistent with the coiled-coil probability prediction (right dot corresponding to 
the right axes). However, on the C2 isoform, K120Q and S125A show a significant activity 
increase compared to wild type. And L119A, L122A and L129A mutants showed a less significant 
transcriptional activity decrease compared to C3. Based on the predicted scenarios, these 
mutations not only influence the coiled-coil propensity, but also contribute to the coupling 







Chapter 10-Molecular Basis of the Favorable Coupling between the 
Functional (F) domain in the NTD and DBD 
10.1 Abstract 
To explore the molecular basis of allosteric coupling between the F domain and the DBD, 
single point mutations and chimeric constructs were introduced to the C3 isoform and tested using 
the luciferase reporter assay. The results support the hypothesis that there is favorable coupling 
between the F domain and DBD. In the context of the EAM, interpreting the functional effects of 
single point mutations indicated that some residues in the N terminal domain of the D2 isoform 
(GR 331-420) are responsible for coupling the F domain to the DBD. Furthermore, on the DBD, 
involved in coupling to F domain is a surface composed of residues after the first recognition 
helix.   
10.2 Introduction 
It is well-established that DNA response elements often act as allosteric regulators of 
transcription factors. This is also the case for GR, in which binding the GR response element 
(GRE) to DBD favors recruitment of co-regulators to the activation function 1 (AF1) site in the 
NTD [18]. To investigate the allosteric coupling between the NTD and DBD in GR, in chapter 3, 
we carried out the TMAO induced folding experiments on the NTD of the A and C3 isoforms in 
the presence and in absence of DBD. It showed that the DBD stabilizes the F domain in the NTD, 
which indicates there is favorable coupling between the F domain and DBD. 
To explore the molecular basis of the coupling, functional assays were carried out on 
constructs designed to interrupt the coupling. Transcriptional activity measurements of a chimeric 
construct confirmed the favorable coupling between the F domain and DBD. In addition, 
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interpreting the functional effect of single point mutations in the context of the EAM allowed us to 
demonstrate the molecular basis of the allostery. 
10.3 Materials and methods 
Constructs 
Plasmid PJ603-C3 NTD-Gal4 DBD is to express the chimeric construct linking the F 
domain (NTD of C3 isoform) and the DBD (1-147) of the yeast transcription factor Gal4 (Uniprot, 
P04386 ) with a 10 amino acid flexible linker (GTGGSGGSGS). It was codon optimized and 
synthesized by DNA 2.0. 
Plasmid Gal4 UAS -Gluc, to express secreted Gaussia Luciferase under the control of two 
tandem Gal4 upstream activating sequences (Gal4 UAS), was made by inserting an 
oligonucleotide containing two tandem Gal4 UAS, 5’- aattCGGAGTACTGTCCTCCG 
aggaattcagCGGAGTACTGTCCTCCG-3’, into the EcoRI and BamHI sites of the pGluc-miniTK 
vector (NEB).   
All the single point mutations on GR constructs were made by site directed mutagenesis 
[60] as described in chapter 9. 
Western blot 
Western blot protocol is the same as described in Chapter 5 
Transcriptional activity measurement 
Protocol is the same as described in Chapter 5. 
10.4 Results and discussion 
Chimeric construct linking F domain to yeast transcription factor Gal4’s DBD showed 
significantly decreased transcriptional activity compared to natural GR construct 
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As discussed in chapter 8 and shown in Fig.33, mutagenesis within the F domain of 
different isoforms will not distinguish between an influence on F domain stability and a 
perturbation of F domain and DBD coupling; the two scenarios have similar effects on both 
transcriptional activity and binding affinity to GRE. Thus to pinpoint the residues within the F 
domain that are allosterically coupled to the DBD a control construct was designed, in which the F 
domain is tethered to the DNA binding domain of Gal4, a yeast transcription factor. 
Transcriptional activity of the chimeric construct was measured on the Gal4 upstream activating 
sequence driving luciferase expression. As shown in Fig.39, the two-domain construct of natural 
GR C3 isoform has about 30-fold higher transcriptional potency than the chimeric construct. This 
functional analysis suggests that GR DBD stabilizes the F domain and favors the binding of 
co-regulators, supporting the notion of a favorable coupling between F domain of the NTD and 
DBD. 
Mutagenesis on F domain reveals some residues involved in the coupling network 
Multiple single point mutations were introduced into the F domain of the C3 isoform in an 
attempt to identify residues involved in coupling. Several mutations (D335N, S370A, D372N, 
D373N and T376V), showed significantly decreased transcriptional activity compared to wild type 
(as shown in Fig. 40). To check whether the mutations influence F domain stability or co-regulator 
binding, they were also carried out in the context of a chimeric construct composed of the F 
domain and the DNA binding domain of the yeast transcription factor Gal4. As shown in Fig.41 
right panel, the mutations did not significantly change the transcriptional activity on the chimeric 
control construct. These results support the notion that multiple residues in the N terminal domain 
of the D2 isoform (GR 331-420) are responsible for coupling the F domain to DBD, of which 
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D335, S370, D372, D373 and T376 are a subset. 
Mutagenesis on DBD pinpoints some residues involved in coupling to F domain 
To identify residues in the DBD involved in coupling to the F domain, sequence 
conservation analysis was carried out [67] on the DBD of GRs from different species and on the 
whole steroid hormone receptor (SHR) family (Fig.42). Residues that are more conserved in GRs 
from different species and less conserved within the whole SHR family were selected for 
mutations, except when those residues were also in contact with DNA base pairs. As shown in 
Fig.43, multiple mutations (E450Q, R460T, D462N, I464T and R479G) significantly decreased 
transcriptional activity of the C3 isoform. As predicted by our GR EAM model (shown in the left 
panel of Fig.44), mutations influencing DBD stability will significantly decrease the binding 
affinity to GRE, while not significantly influencing the transcriptional activity. In contrast, 
mutations influencing the F domain and DBD coupling will significantly decrease the 
transcriptional activity, while not greatly influencing the binding affinity. 
To further determine whether the decreased transcriptional activity of these mutants is due 
to significantly decreased binding affinity to GRE, dosage curve measurements were carried out 
for the mutants in the dual luciferase assay as shown in the upper right panel of Fig.44. From these 
dosage curves, both the maximum transcriptional activity and the binding affinity (represented by 
EC50) for each mutant can be fitted (as shown in the right bottom panel of Fig.44). Mutations of 
two residues R460 and D462, which are within the dimerization box of DBD, significantly 
decreased binding affinity to GRE, with maximum transcriptional activity being comparable to the 
wild type. Mutations of E450, I464 and R479 did not significantly influence binding to GRE, 
however, significantly lowered transcriptional activity compared to WT, suggesting these residues 
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may be involved in the allosteric coupling network between F domain and DBD. Interestingly, all 
these residues can be mapped on a contiguous surface after the first recognition helix on the DBD. 
In fact, E450 is the first residue that is defined as the lever arm of GR’s DBD, which has been 
proposed to allosterically transmit signal from DBD to other regulatory surfaces [22, 68].  Here, 
we found that a potential surface after the first recognition helix on DBD mediates coupling to the 
F domain in the NTD via residues E450, I464 and R479, which were identified through 
mutagenesis. 
10.5 Conclusions 
The molecular basis of the allosteric coupling between F and DBD was further investigated 
using the functional assays. Single point mutations within the F domain, D335N, S370A, D372N, 
D373N and T376V, significantly decreased transcriptional activity of the C3 isoform, while 
maintaining similar activity on the chimeric construct where the F domain and DBD coupling is 
knocked out. This result suggested that these residues within the F domain may contribute to 
coupling the F domain to DBD. In addition, E450Q, I464T and R478G mutations within the DBD 
on the C3 isoform significantly decrease transcriptional activity compared to wild type, and did 
not change the EC50 significantly. This indicates that these residues are involved in coupling to 








Figure 39 | Domain swapping of GR DBD to Gal4 DBD significantly decrease transcriptional 
activity. 
The luciferase assay dosage curve for C3 isoform (composed of F domain and GR DBD) versus 
chimeric construct (tethering F domain to yeast transcription factor Gal4’s DBD). Changing GR 
DBD to Gal4 DBD decreased transcriptional activity about 30 fold, suggesting favorable coupling 











Figure 40 | Transcriptional activity influence of single point mutations within F domain 
tested on C3 isoform. 
For the mutations that significantly decrease the transcriptional activity (D335N, S370A, D372N, 
D373N and T376V), a Western blot was done to check the protein expression level change as 













Figure 41 | Mutations within F domain on C3 isoform and chimeric construct (F domain 
tethered to Gal4 DBD) to identify residues involved in the F and DBD coupling network  
The effect on transcriptional activity when mutations are introduced to the F domain on F-GR 
DBD (C3 isoform) and F-Gal4 DBD (chimeric construct) can be predicted using the EAM model 
for two scenarios (influencing F domain stability or weakening F and DBD coupling) as shown in 
the left panel. Relative luciferase activity of the single point mutations in D2 NTD of the 
functional (F) domain (D335, S370, D372, D373 and T376) tested on C3 NTDDBD (magenta bars) 
and C3 NTD-Gal4 DBD chimeric construct (blue bars) are shown in the bar graph in the right 











Figure 42 | Sequence conservation analysis of DBD within GRs versus SHRs. 
Normalized sequence conservation index versus residue positions based on full-length human GR. 
The conservation index was calculated from the DBD of GRs in different species and from DBD’s 
of the entire steroid hormone receptor family. Secondary structure of DBD is labeled on top of the 










Figure 43 | Influence on transcriptional activity of single point mutations carried out within 
DBD on C3 isoform. 
For the mutations that significantly decrease the transcriptional activity (E450Q, R460T, D462Q, 











Figure 44 | Mutations within DBD on C3 isoform to identify residues involved in the F and 
DBD coupling network. 
The effect on transcriptional activity and binding affinity when mutations are introduced to the C3 
isoform can be predicted based the EAM model for two scenarios (influencing DBD stability or 
weakening F and DBD coupling) as shown in the left panel. The right top panel shows the 
luciferase assay dosage curve measured for the mutants (E450Q, R460T, D462N, I464T, and 
R479G) that showed a significant transcriptional activity decrease compared to WT. From these 
dosage curves, maximum transcriptional activity and EC50 can be fitted for each construct as 
plotted in the right bottom panel. Among these, E450Q, I464T and R479G mutations showed 
significantly decreased transcriptional activity and relatively minor changes in EC50 compared to 









Chapter 11- Molecular Basis for the Favorable Coupling between the 
Regulatory (R) Domain in the NTD and DBD 
11.1 Abstract 
Interpreting the transcriptional activity and binding affinity data of the eight translational 
isoforms suggests that there is favorable coupling between the regulatory (R) domain in the NTD 
and DBD. In chapter 6, by directly linking the R domains of different translational isoforms to the 
DBD through an eleven amino acid flexible linker, it was found that the R domain unique to A and 
B isoforms is favorably coupled to the DBD. In this chapter, to probe the molecular basis of R 
domain and DBD coupling, different segments of the R domain were linked to the DBD to further 
explore which part of the R domain is involved in the R domain and DBD coupling network. 
Segment 1-85 was confirmed to be involved in coupling to DBD. To probe which residues on the 
DBD are coupled to the R domain, mutational effects on binding affinity were compared between 
R domain linked DBD construct and linker DBD control construct. Results suggest that residues 
C431, V435 and L436 which reside on a surface before the first recognition helix are involved in 
coupling the DBD to the R domain.  
11.2 Introduction 
The R domain in the NTD was found to be favorably coupled to the DBD. To identify the 
molecular basis of coupling, mutagenesis within the R domain on the A and B isoforms was 
originally considered. However, based on EAM predictions shown in Fig.32c&d, weakening R 
domain and DBD coupling will only moderately influence both the transcriptional activity and 
binding affinity of A and B isoforms. The F domain also exists in the A and B isoforms, making it 
more complicated to interpret the mutagenesis effect. In this context, a conjoined construct that is 
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more straightforward to study R domain and DBD allostery was designed. As discussed in chapter 
6, this conjoined construct, in which R domain was directly linked to DBD through a flexible 
linker, showed significantly increased binding affinity to GRE compared with the DBD construct. 
This confirmed the favorable coupling between the R domain and DBD and verified that the R 
domain and DBD conjoined construct is able to explore the R domain and DBD coupling 
mechanism. So in this chapter, truncations and mutagenesis were introduced to the conjoined 
construct or DBD to pinpoint the molecular basis of coupling between R domain and DBD.  
11.3 Materials and methods 
Constructs 
Plasmid PJ603-1-97-11aa-DBD construct to express GR 1-97 linked to DBD with an 
eleven amino acids GTGGSGGSGGS flexible linker was made by ligating together the PCR 
product deleting the codons for GR 98-420 from PJ603-A NTDDBD with BamHI and KpnI sticky 
ends and an oligonucleotide coding for GTGGSGGSGGS. Plasmid PJ603-27-97-11aa-DBD, 
-86-97-11aa-DBD, -90-97-11aa-DBD, -1-85-11aa-DBD, -1-27-11aa-DBD and -11aa-DBD were 
made by inserting the codons for each construct amplified from PJ603-1-97-11aa-DBD into the 
NheI and XhoI site of PJ603 vector. 
All the single point mutations on GR constructs were made by site directed mutagenesis 
[60] as described in chapter 9. 
Competitive transfection assay 
The same as described in Chapter 5.  
11.4 Results and discussion 
Segment within R domain potentially involved in the R domain and DBD coupling network  
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As discussed in chapter 6 shown in Fig. 26, R domains of A and B isoforms are favorably 
coupled to the DBD. In theory, it is desirable to check which segment or residues within the R 
domain are involved in the coupling in detail. However, both the stability of the R domain and the 
coupling energy between R domain and DBD will significantly influence the binding affinity of 
DBD to GRE (as predicted by EAM model shown in Fig.45 left panel), thus it is difficult to 
identify which segment is specifically involved in the coupling through mutagenesis. To double 
check whether the R domain unique to A and B is involved in coupling to DBD, segment 1-85 
(which is unique to the R domain of the A and B isoform) and segment 1-27 (which is the 
difference between the A and B isoforms) were also directly linked to the DBD through the 
flexible linker. As shown in Fig.45 right panel, linking segment 1-85 to DBD has a similar 
stabilizing effect on the DBD compared to segment 1-97, which is consistent with linking 86-97 
and 90-97 to DBD not having a significant effect. Linking segment 1-27 to DBD showed a 
stabilizing effect on DBD, which is consistent with segment 1-97 having a stronger stabilizing 
effect on DBD than segment 1-27. Thus all the current data suggest that some residues within the 
R domain unique to the A and B isoforms (segment 1-85) may be involved in the coupling to 
DBD. 
Residues within DBD potentially involved in the R domain and DBD coupling network  
To identify residues on DBD coupled to the R domain, single point mutations were selected 
(L422A, S425G, C431Y, V435A, L436A, L482Y and Q483E) that did not cause significant 
changes in transcriptional activity of the C3 isoform (as shown in Fig.43). All these mutations 
were introduced to the RA-linker-DBD construct and linker-DBD construct. As predicted from the 
EAM model (shown in Fig.46 middle panel), mutations influencing DBD stability will 
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significantly change the binding affinity of both the two constructs. In contrast, mutations 
influencing the R domain and DBD coupling will only change the binding affinity of 
RA-linker-DBD construct. Competitive transfection assays were carried out for all these constructs 
as shown in Fig.46 bottom panel. The EC50 for each competitor construct can be fitted from these 
assays as shown in Fig.47. Mutations (C431Y, V435A and L436A) showed significantly different 
influences on linker-DBD construct and RA-linker-DBD construct. These mutations did not 
significantly influence the binding affinity of linker-DBD-construct, and significantly decreased 
the binding affinity of RA-linker-DBD construct. Thus, C431, V435 and L436 within DBD are 
found to be involved in the allosteric coupling network between R domain and DBD. 
11.5 Conclusions 
By linking different segments of the R domain to the DBD through a flexible linker and 
measuring the influence on DNA binding affinity, it was found that segment 1-85, which is unique 
to A and B isoforms, is involved in mediating the allosteric coupling between R domain and DBD. 
When comparing the mutagenesis effect on the construct with R domain conjoined to DBD to the 
DBD, we found that some residues (C431, V435 and L436), which reside on a surface before the 





Figure 45 | Truncations of the construct with the R domain joined to the DBD to identify 
segment involved in the R domain and DBD coupling network. 
The effect on binding affinity when changing R domain length can be predicted with an EAM 
model for two scenarios (influencing R domain stability or weakening R and DBD coupling) as 
shown in the left panel. Competitive transfection assay curves were measured and shown in the 
right top panel for: linker-DBD construct, 1-97-linker-DBD construct, 1-85-linker-DBD construct, 
86-97-linker-DBD construct, 90-97-linker-DBD construct, 27-97-linker-DBD construct and 
1-27-linker-DBD construct. The EC50 can be fitted from these competitive transfection assays for 
each of these competitor constructs as shown in the right bottom panel. Based on the predicted 










Figure 46 | Mutations within DBD and RA-DBD construct to identify residues involved in the 
R and DBD coupling network. 
The effect on binding affinity when mutations are introduced to DBD or RA and DBD conjoined 
construct can be predicted based on the EAM model for two scenarios (influencing DBD stability 
or weakening R and DBD coupling) as shown in the left panel. Competitive transfection assays 
were carried out for single point mutations C431Y, V435A and L436A on both DBD construct and 











Figure 47 | EC50 of DBD and RA-DBD constructs’ mutants fitted from competitive 
transfection assay. 
EC50 can be fitted from competitive transfection assays for each of these mutants and expressed 
as a relative value compared to wild type. These three mutations (C431Y, V435A and L436A) 
showed significantly increased EC50 on the RA conjoined to DBD construct, and no significant 











Chapter 12- Concluding Remarks 
12.1 Summary 
In this dissertation, allostery mediated by an ID domain in GR was investigated by 
combining biophysical characterizations, cell based functional assays, and an Ensemble Allosteric 
Model simulation. The intrinsically disordered NTD was found to be composed of two 
functionally distinct regions, F domain and R domain, which are unfavorably coupled. Importantly, 
both the R and F domains are favorably coupled to DBD. The allosteric coupling model was able 
to provide insight into the reason why there is a lack of correlation between the binding affinity 
and transcriptional activity of GR translational isoforms. The EAM was invaluable in guiding our 
investigation into the molecular basis for the allostery (as summarized in Fig.48). Some residues 
in the NTD of the D2 isoform contribute to coupling the F domain to the DBD, and a surface on 
the DBD composed of residues after the first recognition helix is involved in coupling to the F 
domain. For the R domain and DBD allosteric coupling network, segment 1-85 of R domain is 
engaged in the favorable coupling to DBD. On the DBD, a surface composed of some residues 
before the first recognition helix is favorably coupled to the R domain. For the negative coupling 
between the R and F domains, some residues within segment 90-97, which is the R domain of the 
C2 isoform, and some residues within segment 119-132, which is a predicted coiled-coil in the F 
domain, are involved in the coupling network. 
12.2 Toward future applications 
This study suggests a framework in the methodology to study allostery, especially in IDPs. 
The combination of in vitro biophysical studies, cell based functional assays and EAM makes it 
possible to study a complicated allosteric system composed of long ID regions, as well as 
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structured domains. Predictions from the EAM guided our mutagenesis efforts by assisting in the 
selection of the mutation types and isoforms. These prediction-guided experiments were essential 
in our efforts to interpret the mutational data. The EAM quantitatively captures the variable 
transcriptional activity and binding affinity of the constitutively active constructs of the eight GR 
translational isoforms. For example, compared to the full-length A isoform, the higher 
transcriptional activity and lower binding affinity to GRE of the C3 isoform can be understood. In 
the literature, the heightened transcriptional activity of the C3 isoform is explained by removal of 
the steric hindrance effect of the R domain on the functional domain [69]. It is one possible 
scenario that could contribute to the negative coupling between the R domain and F domain. 
However, this interpretation does not explain the effect on the DNA binding affinity 
The molecular basis of allostery paves a potential way for designing allosteric drugs, which 
have multiple advantages over orthosteric drugs as reviewed in the literature recently [63-65]. In 
the SHR family, the NTD almost has no sequence conservation between different members. In this 
sense, the NTD is a good target for drug development. However, the ID characteristics make it 
non trivial to target. Elucidating the residues involved in the allosteric coupling network will 






Figure 48 | Cartoon summary of the molecular basis of allosteric coupling in GR 
constitutively active two-domain constructs 
Cartoon summary of the coupling scheme in GR showing the residues in the DBD, R- and 
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Appendix 2. C code for GR EAM model 
/*consider 5% is poised to respond. more detailed binding affinity and activity compare*/ 
 
/* How to compile? 









float CRANTDDBD, BindingcompetentANTDDBD; 
float CRBNTDDBD, BindingcompetentBNTDDBD; 
float CRC1NTDDBD, BindingcompetentC1NTDDBD; 
float CRC2NTDDBD, BindingcompetentC2NTDDBD; 
float CRC3NTDDBD, BindingcompetentC3NTDDBD; 
















int nthreads, nprocs; 
const float  R=0.001986;  /*   Cal/mol -K */ 
float conval; 








stepsize = 500;  /*   Cal/mol */ 





/* Determine number of Processors and threads */ 
#pragma omp single 
{ 
nthreads = omp_get_num_threads(); 
nprocs = omp_get_num_procs(); 
printf("Number of Threads per CPU    : %5d \n",nthreads); 




fprintf(outfile,"deltaGf deltaGd  deltaGrA deltaGrB deltaGrC1 deltaGrC2 deltagfd
 deltagrC1f deltagrC1f deltagrC1f deltagrC2f deltagrAddeltagrBd
 CRANTDDBD BindingcompetentANTDDBD CRBNTDDBD
 BindingcompetentBNTDDBD CRC1NTDDBD BindingcompetentC1NTDDBD
 CRC2NTDDBD BindingcompetentC2NTDDBD CRC3NTDDBD
 BindingcompetentC3NTDDBD               \n"); 
 









m,deltagrAdhistogram,deltagrBdhistogram,deltagfdhistogram,conval,deltagGRE, stepsize, outfile, 
outfile2,deltagrC1d,deltagrC2d) 
 
  for (deltaGd = -2000 ; deltaGd <= -500 ; deltaGd = deltaGd + 500) 
  { 
  for (deltaGrA = -1500 ; deltaGrA <=2500 ; deltaGrA = deltaGrA + 500) 
  { 
  for (deltaGrB = -1500 ; deltaGrB <= 2500 ; deltaGrB = deltaGrB + 500) 
  { 
  for (deltaGrC1 = -1500; deltaGrC1 <=2500 ; deltaGrC1 = deltaGrC1 + 500) 
  { 
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  for (deltaGrC2 = -1500; deltaGrC2 <=2500 ; deltaGrC2 = deltaGrC2 + 500) 
  { 
  for (deltagfd = 5000 ; deltagfd <= 7000 ; deltagfd = deltagfd + 500) 
  { 
  for (deltagrAf = -3000 ; deltagrAf <= -500 ; deltagrAf = deltagrAf + 500) 
  { 
  for (deltagrBf = -3000 ; deltagrBf <= -500 ; deltagrBf = deltagrBf + 500) 
  { 
  for (deltagrC1f = -3000 ; deltagrC1f <= -500 ; deltagrC1f = deltagrC1f + 500) 
  { 
  for (deltagrC2f = -3000 ; deltagrC2f <= -500 ; deltagrC2f = deltagrC2f + 500) 
  { 
   for (deltagrAd = 200; deltagrAd <= 2000 ; deltagrAd = deltagrAd + 200) 
  { 
  for (deltagrBd = 200 ; deltagrBd <= 2000 ; deltagrBd = deltagrBd + 200) 
  { 
   /*fprintf(stderr,"deltaGd %i\n", deltaGd);*/ 






deltagfd+deltaGrA+deltagrAd+ deltagrAf))*(1+exp((conval)*deltagGRE))) +   






















exp((conval)*(deltaGd+deltaGf+deltagfd+deltaGrA+ deltagrAd+deltagrAf)))  +   
exp((conval)*(deltaGrA+ deltagrAd+deltagrAf))/(1+exp((conval)*(deltaGd+deltagfd+ 
deltagrAd))+exp((conval)*(deltaGf+deltagfd+deltagrAf))+ 












                        






eltagfd+deltaGrB+deltagrBd+ deltagrBf))*(1+exp((conval)*deltagGRE))) +   






















exp((conval)*(deltaGd+deltaGf+deltagfd+deltaGrB+ deltagrBd+deltagrBf)))  +   
exp((conval)*(deltaGrB+ deltagrBd+deltagrBf))/(1+exp((conval)*(deltaGd+deltagfd+ 
deltagrBd))+exp((conval)*(deltaGf+deltagfd+deltagrBf))+ 



















aGf+deltagfd+deltaGrC1+deltagrC1d+ deltagrC1f))*(1+exp((conval)*deltagGRE))) +   






















exp((conval)*(deltaGd+deltaGf+deltagfd+deltaGrC1+ deltagrC1d+deltagrC1f)))  +   
exp((conval)*(deltaGrC1+ deltagrC1d+deltagrC1f))/(1+exp((conval)*(deltaGd+deltagfd+ 
deltagrC1d))+exp((conval)*(deltaGf+deltagfd+deltagrC1f))+ 




















aGf+deltagfd+deltaGrC2+deltagrC2d+ deltagrC2f))*(1+exp((conval)*deltagGRE))) +   






















exp((conval)*(deltaGd+deltaGf+deltagfd+deltaGrC2+ deltagrC2d+deltagrC2f)))  +   
exp((conval)*(deltaGrC2+ deltagrC2d+deltagrC2f))/(1+exp((conval)*(deltaGd+deltagfd+ 
deltagrC2d))+exp((conval)*(deltaGf+deltagfd+deltagrC2f))+ 














    CRC3NTDDBD = exp((conval)*deltagGRE)*(1+exp((conval)* deltagGRE)) / 
(1+exp(( conval)*(deltaGd+deltagfd))+exp(( conval)*(deltaGd+deltaGf+deltagfd))+exp(( conval)
*deltagGRE)+exp((conval)*(deltaGf+ deltagfd))*(1+exp((conval)*deltagGRE))); 
    BindingcompetentC3NTDDBD = 1 / ( 1 + 
exp((conval)*(deltaGd+deltagfd))+exp(( conval)*(deltaGf+deltagfd))+exp((conval)*( deltaGd+de
ltaGf+deltagfd)))  + exp((conval)*(deltaGf+deltagfd)) / (1+exp((conval)*(deltaGd+deltagfd)) 





    BindingcompetentRBDBD=(1+ 
exp(conval*(deltaGrB+deltagrBd)))/(1+exp(conval*(deltaGd+deltagrBd))+exp(conval*(deltaGrB
+deltagrBd))+exp(conval*(deltaGrB+deltaGd+deltagrBd))); 
    BindingcompetentDBD=1/(1+exp(conval*deltaGd)); 
                         
    





BindingcompetentC3NTDDBD/BindingcompetentANTDDBD);)*/      
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   if 
( (BindingcompetentRADBD<2*BindingcompetentRBDBD)&&(BindingcompetentRADBD>Bin
dingcompetentRBDBD)&& (BindingcompetentRBDBD>BindingcompetentDBD) && 
(BindingcompetentC3NTDDBD>BindingcompetentDBD) && (BindingcompetentANTDDBD 
<=0.4) 
&&(CRC3NTDDBD/exp((conval)*deltagGRE) >=0.05)&&(CRANTDDBD/CRBNTDDBD < 1) 
&& (CRANTDDBD/CRBNTDDBD > 0.68)&& (BindingcompetentANTDDBD > 
BindingcompetentBNTDDBD) && (BindingcompetentANTDDBD < 
1.5*BindingcompetentBNTDDBD) && (CRANTDDBD/CRC1NTDDBD < 1) && 
(CRANTDDBD/CRC1NTDDBD >0.67)&& (BindingcompetentANTDDBD > 
BindingcompetentC1NTDDBD) && (BindingcompetentANTDDBD < 
2.5*BindingcompetentC1NTDDBD)&& (CRANTDDBD/CRC2NTDDBD > 1) && 
(CRANTDDBD/CRC2NTDDBD <1.5)&& (BindingcompetentANTDDBD > 
BindingcompetentC2NTDDBD) && (BindingcompetentANTDDBD < 
2.5*BindingcompetentC2NTDDBD) && (CRANTDDBD/CRC3NTDDBD <0.33) && 
(CRANTDDBD/CRC3NTDDBD >0.2) && (BindingcompetentANTDDBD > 
BindingcompetentC3NTDDBD) && (BindingcompetentANTDDBD < 
2*BindingcompetentC3NTDDBD)&&(CRBNTDDBD/CRC1NTDDBD > 1) && 
(CRBNTDDBD/CRC1NTDDBD < 1.5)&& (BindingcompetentBNTDDBD > 
BindingcompetentC1NTDDBD) && (BindingcompetentBNTDDBD < 
2.5*BindingcompetentC1NTDDBD)&& (CRBNTDDBD/CRC2NTDDBD > 1) && 
(CRBNTDDBD/CRC2NTDDBD < 2)&& (BindingcompetentBNTDDBD > 
BindingcompetentC2NTDDBD) && (BindingcompetentBNTDDBD < 
2.5*BindingcompetentC2NTDDBD) && (CRBNTDDBD/CRC3NTDDBD <0.4) && 
(CRBNTDDBD/CRC3NTDDBD >0.2) && (BindingcompetentBNTDDBD > 
BindingcompetentC3NTDDBD) && (BindingcompetentBNTDDBD < 
2*BindingcompetentC3NTDDBD) &&  (CRC1NTDDBD/CRC2NTDDBD > 1) && 
(CRC1NTDDBD/CRC2NTDDBD <2)&& (BindingcompetentC1NTDDBD > 
BindingcompetentC2NTDDBD) && (BindingcompetentC1NTDDBD < 
2.5*BindingcompetentC2NTDDBD) && (CRC1NTDDBD/CRC3NTDDBD <0.4) && 
(CRC1NTDDBD/CRC3NTDDBD >0.2) && (BindingcompetentC1NTDDBD < 
BindingcompetentC3NTDDBD) && (BindingcompetentC1NTDDBD > 
0.5*BindingcompetentC3NTDDBD) && (CRC2NTDDBD/CRC3NTDDBD <0.33) && 
(CRC2NTDDBD/CRC3NTDDBD >0.15) && (BindingcompetentC2NTDDBD < 
BindingcompetentC3NTDDBD) && (BindingcompetentC2NTDDBD > 
0.5*BindingcompetentC3NTDDBD)) 
    { 
  fprintf(stderr,"good%i\n",stepsize); 
  deltaGdhistogram[(deltaGd+2000)/500]++; 
  deltaGrAhistogram[(deltaGrA+1500)/stepsize]++; 
  deltaGrBhistogram[(deltaGrB+1500)/stepsize]++; 
  deltaGrC1histogram[(deltaGrC1+1500)/stepsize]++; 
  deltaGrC2histogram[(deltaGrC2+1500)/stepsize]++; 
     deltagfdhistogram[(deltagfd-5000)/stepsize]++; 
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  deltagrAfhistogram[(deltagrAf+3000)/stepsize]++; 
  deltagrBfhistogram[(deltagrBf+3000)/stepsize]++; 
  deltagrC1fhistogram[(deltagrC1f+3000)/stepsize]++; 
  deltagrC2fhistogram[(deltagrC2f+3000)/stepsize]++; 
  deltagrAdhistogram[(deltagrAd-200)/200]++; 
  deltagrBdhistogram[(deltagrBd-200)/200]++;              
 /*fprintf(stderr,"deltagrBd %i\n", deltagrBd);*/      
  
fprintf(outfile,"%7d %7d %7d %7d %7d %7d %7d %7d %7d %7d %7d %7d %7d %12.8f %12.8f
 %12.8f %12.8f %12.8f %12.8f %12.8f %12.8f %12.8f %12.8f\n" , deltaGf, deltaGd, deltaGrA, 
deltaGrB, deltaGrC1, deltaGrC2, deltagfd, deltagrAf,  deltagrBf, deltagrC1f, deltagrC2f, 


























 for (i=0; i<=3; i++) 
 {fprintf(outfile2, "deltaG(DBD): "); 
 fprintf(outfile2, "%5d %100d\n", -2000+i*500, deltaGdhistogram[i]);} 
        
 for (i=0; i<=4; i++) 
 {fprintf(outfile2, "deltagint(F,DBD): "); 
 fprintf(outfile2, "%5d %100d\n", 5000+i*stepsize, deltagfdhistogram[i]);} 
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 for (i=0; i<=8; i++) 
 {fprintf(outfile2, "deltaG(RA): "); 
 fprintf(outfile2, "%5d %100d\n", -1500+i*stepsize, deltaGrAhistogram[i]);} 
 
 for (i=0; i<=8; i++) 
 {fprintf(outfile2, "deltaG(RB): "); 
 fprintf(outfile2, "%5d %100d\n", -1500+i*stepsize, deltaGrBhistogram[i]);} 
        
 for (i=0; i<=8; i++) 
 {fprintf(outfile2, "deltaG(RC1): "); 
 fprintf(outfile2, "%5d %100d\n", -1500+i*stepsize, deltaGrC1histogram[i]);} 
        
 for (i=0; i<=8; i++) 
 {fprintf(outfile2, "deltaG(RC2): "); 
 fprintf(outfile2, "%5d %100d\n", -1500+i*stepsize, deltaGrC2histogram[i]);}    
        
 for (i=0; i<=5; i++) 
 {fprintf(outfile2, "deltagint(RA,F): "); 
 fprintf(outfile2, "%5d %100d\n", -3000+i*stepsize, deltagrAfhistogram[i]);} 
        
 for (i=0; i<=5; i++) 
 {fprintf(outfile2, "deltagint(RB,F): "); 
 fprintf(outfile2, "%5d %100d\n", -3000+i*stepsize, deltagrBfhistogram[i]);} 
 
for (i=0; i<=5; i++) 
 {fprintf(outfile2, "deltagint(RC1,F): "); 
 fprintf(outfile2, "%5d %100d\n", -3000+i*stepsize, deltagrC1fhistogram[i]);} 
        
for (i=0; i<=5; i++) 
 {fprintf(outfile2, "deltagint(RC2,F): "); 
 fprintf(outfile2, "%5d %100d\n", -3000+i*stepsize, deltagrC2fhistogram[i]);}    
        
 for (i=0; i<=9; i++) 
 {fprintf(outfile2, "deltagint(RA,DBD): "); 
 fprintf(outfile2, "%5d %100d\n", 200+i*200,deltagrAdhistogram[i]);} 
        
 for (i=0; i<=9; i++) 
 {fprintf(outfile2, "deltagint(RB,DBD): "); 
 fprintf(outfile2, "%5d %100d\n", 200+i*200, deltagrBdhistogram[i]);} 
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